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Zusammenfassung
Die Behandlung von Krebs mit Photonenstrahlung hat sich in den letzten Jahrzehnten
rasant entwickelt mit dem Ziel, das therapeutische Verhältnis zu verbessern, indem dem
Tumor eine letale Dosis verabreicht wird bei gleichzeitiger Schönung des benachbarten,
normalen Gewebes. Da der Erfolg der Krebstherapie von der Qualität der Dosisabgabe
abhängt, wurde ein Qualitätssicherungsprogramm (QA, Quality Assurance) etabliert, um
eine systematische Überwachung der Qualität und Angemessenheit der Patientenbehand-
lung durch die sogenannte Bestrahlungskette der Strahlentherapie sicherzustellen. Solch
ein Programm sammelt Informationen aus verschiedenen Bereichen der Medizinischen
Physik. Die Hauptaufgabe von Medizinphysikern besteht insbesondere darin, die Abgabe
der geplanten Dosis an den Patienten sicherzustellen, wobei die Unsicherheit unter den
international anerkannten Grenzwerten liegen soll. Die Bestrahlung ist jedoch mit der En-
twicklung der Technologie komplizierter geworden. Daher ist die Entwicklung fortschrit-
tlicher QA-Werkzeuge und -Methoden für neue Ausrüstungen und Techniken erforder-
lich. In der Praxis werden verschiedene QA-Protokolle verwendet, die auf kommerziellen
oder selbstentwickelten Tools und Methoden basieren, um internationalen Empfehlun-
gen Rechnung zu tragen. Die gegenwärtige Praxis hat jedoch Beschränkungen, entweder
aufgrund der Abhängigkeit von Dosisberechnung oder Dosierungssystemen, was ein ar-
beitsintensives Verfahren oder mangelnde Genauigkeit impliziert. Das Ziel dieser Ar-
beit ist die Entwicklung eines QA-Tools für die patientenindividuelle Qualitätssicherung
vor der Behandlung. Dieses Werkzeug ist ein dosimetrischer Ansatz, der schnell, genau
und dreidimensional (3D) ist, unabhängig vom Behandlungsplanungssystem (TPS, treat-
ment planning system) und der Abgabemaschine, dabei sensitiv für inhärente Fehler. Das
Electronic Portal Imaging Device (EPID) ist ein planarer Detektor, der starr an mod-
ernen Linacs befestigt ist, die für Bildgebungszwecke verwendet werden. Da diese
Detektortypen über dosimetrische Merkmale verfügen, wurden diese Merkmale des
EPID, das an der Abteilung für Radiologie Onkologie der Universitätsklinik München
(Klinikum der Universität München, Ludwig-Maximilians-Universität) installiert wurde,
explizit untersucht. Ausgehend von den Erkenntnissen aus der EPID-Charakterisierung
wurde ein Verfahren zur Kalibrierung des als Dosimeter in Wasser zu verwendenden
EPID vorgestellt, wodurch das aus dem EPID gewonnene zweidimensionale (2D) Bild
in eine 2D-Dosisverteilung umgewandelt werden kann. Die Genauigkeit der Kalib-
rierungsmethode wurde anhand der weit verbreiteten Gamma-Bewertung gegenüber Ref-
erenzdosimetern validiert. Das vorgeschlagene Verfahren liefert die 2D-Dosisverteilung
mit einer Genauigkeit, die mit der Referenz von Dosimetern in einem Wassermedium
vergleichbar ist, jedoch mit einer besseren räumlichen Auflösung und kürzeren Auf-
bauzeiten. In Anbetracht der Einführung neuer Behandlungstechniken wie der inten-
sitätsmodulierten Strahlentherapie (IMRT, intensity modulated radiation therapy) und der
volumetrisch modulierten Arc-Therapie (VMAT) ist eine Validierung unter dynamischen
Gantry-Bedingungen von entscheidender Bedeutung, um festzustellen, ob die richtige
Dosis unter dem richtigen Gantry-Winkel abgegeben wird. Zu diesem Zweck ist ein drei-
dimensionaler Dosimetrieansatz erforderlich. Daher wurde in dieser Arbeit ein neuartiger
Ansatz zur Rekonstruktion einer 3D-Dosisverteilung aus 2D-Dosisverteilungen entwick-
elt. Eine Reihe mathematischer Operationen wurde implementiert, um eine 3D-Verteilung
zu erzeugen, die mit der gewünschten räumlichen Auflösung übereinstimmt und eine mit
der TPS-Dosisberechnung vergleichbare Genauigkeit aufweist. Die Operationen wurden
v
in einen Algorithmus eingebettet, der die 2D-Dosisverteilungen auf verschiedenen Stufen
rückprojiziert und so eine 3D-Dosisverteilung in einem virtuellen zylindrischen Phan-
tom bildet (rekonstruiert). Die rekonstruierten 3D-Dosisverteilungen wurden unter Ver-
wendung der Gamma-Bewertung mit allgemein empfohlenen Kriterien (3%, 3 mm) für
herkömmliche und komplexe klinische Behandlungspläne gegenüber Referenzmessungen
validiert. Die Auswertung der verschiedenen IMRT- und VMAT-Pläne hat gezeigt, dass
die Übereinstimmung den allgemeinen Toleranzwert (d. h. 95%) eingehalten hat. Da das
QA-Instrument in der Lage sein sollte, dosimetrische und geometrische Ungenauigkeiten
zu erkennen, wurde die Sensitivität der entwickelten Rekonstruktionsmethode bei beab-
sichtigten Abweichungen der Dosisabgabe in Bezug auf den Referenzplan bewertet. Es
wird gezeigt, dass die Rekonstruktionsmethode in der Lage ist, geometrische Fehler des
Multilamellenkollimator (MLC, multileaf colimator) in der Größenordnung von 2 mm,
eine Winkelverschiebung des Portalwinkels von 1 Grad und einen dosimetrischen Fehler
von± 4% zu erkennen. Die entwickelte Arbeit stellt eine bevorzugte Methode gegenüber
anderen in der Literatur vorgeschlagenen und auch gegenüber kommerziellen Geräten
vor. Der Ansatz ist prädiktionsfrei, schnell und einfach in der klinischen Routine zu
implementieren. Ausgehend von einer Aufnahme an Luft wird eine wasseräquivalente
3D-Dosisverteilung mit relativ hoher Auflösung ohne externes Phantom oder Dosime-
triegerät erstellt. Der vorgeschlagene Ansatz erhöht somit die Effizienz und Genauigkeit
der QA-Protokolle in der Strahlentherapie. Es ist möglich, die vorgeschlagenen Arbeiten
in ein umfassendes patientenspezifisches QA-Programm zu integrieren, welches auch eine
auf MC basierende Dosisberechnung und die vollständige Automatisierung des gesamten
QA-Verfahrens umfasst.
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Abstract
Treatment of cancer using photon radiation has rapidly developed in the last few decades.
The development has aimed at improving the therapeutic ratio by delivering a lethal ra-
diation dose to the tumor with sparing adjacent normal tissue. As the success of cancer
radiation therapy depends on the quality of dose delivery, a Quality Assurance (QA) pro-
gram has been established to assure the objective of systematic monitoring of the quality
and appropriateness of patient care through the radiotherapy treatment chain. While such
a program requires inputs from different disciplines, the primary task of medical physi-
cists, in particular, is to ensure the delivery of the planned dose to the patient with an
uncertainty below internationally accepted limits. However, the dose delivery has be-
come more complicated with the development of technology. Hence, the development
of advanced QA tools and methods to accommodate new equipments and techniques is
required. In practice, different QA protocols relying on commercial or -in-house- devel-
oped tools and methods are used to accommodate international recommendations. How-
ever, the current practice has limitations due to either dependency on dose calculation or
dose delivery systems, implying labor intensive procedure or lack of accuracy. The aim
of the thesis is to develop a QA tool for patient-specific pre-treatment QA. The tool is
to be identified as a dosimetric approach which is fast, accurate, three-dimensional (3D),
independent of the treatment planning system (TPS) and delivery machine and sensitive
to error. Electronic Portal Imaging Device (EPID) is a planar detector rigidly attached to
modern linacs used for imaging purposes. As these types of detectors offer dosimetric
features, the dosimetric characteristics of the EPID installed at the Department of Radi-
ation Oncology of the University Clinic of Munich (Klinikum der Universität München,
Ludwig-Maximilians-Universität) have been explicitly investigated. Making use of the
knowledge gained from EPID characterization, a method to calibrate the EPID to be used
as a dosimeter in water has been presented, thus converting the two-dimensional (2D) im-
age, as acquired from EPID, into a 2D dose distribution. The accuracy of the calibration
method has been validated against reference dosimeters by using the widely used gamma
evaluation. The proposed method provides the 2D dose distribution with accuracy com-
parable to reference dosimeters in a water medium but better spatial resolution and set-up
time efficiency. However, considering the introduction of new treatment techniques such
as Intensity Modulated Radiation Therapy (IMRT) and Volumetric Modulated Arc Ther-
apy (VMAT), a validation under dynamic gantry condition becomes crucial to determine
that the correct dose is delivered at the correct gantry angle. For this purpose, a 3D dosi-
metric approach is required. Hence, a novel approach to reconstruct a 3D dose distribution
from 2D dose distributions has been developed in this thesis. A series of mathematical
operations have been implemented to generate a 3D distribution matching the desired
spatial resolution and having comparable accuracy with the TPS dose calculation. The
operations have been embedded in an algorithm that back-project the 2D dose distribu-
tions at different levels thus forming (reconstructing) a 3D dose distribution in a virtual
cylindrical phantom. The reconstructed 3D dose distributions have been validated using
gamma evaluation with commonly recommended (3%, 3 mm) criteria for conventional
and complex clinical treatment plans against reference measurements. The evaluation for
the different IMRT and VMAT plans has resulted in passing rate exceeding the common
tolerance level (i.e. 95%). As the rationale of the QA tool is to be capable of detect-
ing dosimetric and geometric inaccuracy, the sensitivity of the developed reconstruction
methodology has been evaluated in the presence of intentional dose delivery deviations
with respect to the reference plan. The reconstruction methodology has demonstrated to
be sensitive to geometric errors of the multi-leaf collimator (MLC) in the order of 2 mm,
gantry angle shift of 1 degree and dosimetric error of ±4%. The developed work presents
a preferable methodology over others proposed in the literature and also over commercial
devices. The approach is prediction-free, fast and easy to implement in clinical routine.
Starting from an in-air acquisition, a water equivalent 3D dose distribution with relatively
high resolution is obtained without an external phantom or dosimetric device. Thus, the
proposed approach adds efficiency and accuracy to QA protocols in radiation therapy.
The proposed work is foreseen to be integrated into a comprehensive patient-specific QA
program including an MC based dose calculation and full automation of the whole QA
procedure.
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Chapter 1
Introduction and Motivation
Cancer is a group of diseases defined by an abnormal cell growth in any body organ
spreading to another organ in a process called metastasizing. Metastases are the primary
cause of death from cancer. Globally, cancer is the second leading cause of death [1]
[2]. In 2013, there were 14.9 million incident cancer cases and 8.2 cancer-related deaths
recorded worldwide [3]. Scientists predict that 23.6 million cases will be diagnosed with
cancer worldwide each year by 2030 [4]. In order to fight this major societal challenge,
three major types of treatment are typically adopted, individually or more often in com-
bination. Namely: surgery, chemotherapy, and radiotherapy. Less common procedures
and techniques for cancer treatment include immunotherapy, targeted therapy, stem cell
transplant and hormone therapy. Choosing the adequate type of treatment depends on the
cancer type and location. The treatment plan can include one or a combination of types
mentioned above. However, radiotherapy is involved in about 50% of cancer treatment
course in Europe and the US [5] [6]. Radiotherapy is based on the use of ionizing radia-
tion (photons, electrons, ions and -in a few cases- neutrons) to deliver conformal dose (i.e.
energy per mass) to the cancer target. Radiotherapy aims to improve the therapeutic ratio
by delivering a lethal radiation dose to the tumor with sparing adjacent normal tissue.
Using photon for cancer treatment has begun in 1896 shortly after the discovery of X-rays
by Röntgen. Since then, a substantial improvement in modalities and techniques has been
implemented up to our current day.
An overview of the state of the art of radiation therapy modalities and techniques will be
presented in this chapter. Then, a brief description about quality assurance programs in
clinics will be addressed. Finally, the aim of this thesis will be presented.
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1.1 Modern radiation therapy
Radiation therapy can be delivered using different modalities. Modalities are categorized
based on the location of the radiation source relative to the patient (i.e. external or internal)
and the type of radiation. Independently of the delivery modalities, the process starts,
in general, with the treatment planning based on a patient image obtained using X-ray
Computed Tomography (CT). Recently, functional and/or anatomical imaging modalities
such as Positron Imaging Tomography (PET) and Magnetic Resonance Imaging (MRI)
have been introduced to complement the anatomical information of the CT images(s) [7].
The tumor and the normal tissue are delineated and contoured on the patient image. The
radiation delivery technique is chosen based on clinical consideration, including shape,
size and location of the tumor. A brief description of radiation delivery modalities is
given in the following:
1.1.1 External radiation therapy
1.1.1.1 Photon external radiation therapy
Photons with high energy (∼MeV) either emerge from a nucleus (gamma irradiation) or
originated from its orbits (X-ray) are used to deliver a conformal dose to patients. Specif-
ically, gamma rays originate from radioactive nuclei, while X-rays originate in a target
bombarded with energetic electrons. The technologies used for dose delivery purpose
include Linear accelerator (linac), Gamma knife, Tomotherapy and cyberknife [8]. The
most common and versatile technology in use in clinics worldwide is the linac whereas
the other modalities are designed to treat specific cancer types and locations. Since the
linac is also the technology of interest in this work, a more detailed description will follow
in section 2.3.
1.1.1.2 Particle external radiation therapy
The external radiation treatment in particle therapy uses accelerated beams (up to few
hundreds MeV/u) of protons or heavier ions. By definition, electron and neutron therapy
may also be categorized as particle therapy. But due to its different source and type of
interactions, particle therapy is usually referred to ion beam therapy to exclude the elec-
trons and neutrons. Ions have different dosimetric characteristics than the more widely
used photons when traversing media. In water, the typical energy deposition of the photon
beam is exponentially decreasing with depth after the build-up region. Differently, ions
show a steady energy deposition for a certain depth and then a steep rise to the peak (the
“Bragg peak”) near the end of their range (figure 1.1) [8]. These characteristics of ions
give the advantage in treatment by depositing the maximum energy within the target (the
tumor) and sparing the healthy tissue from unwanted energy deposition. Although this
2
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advantage represents a game changer in radiation therapy, it has not yet been considered
for (entirely) replacing conventional photon therapy. It is argued that though the physics
of particles and their interaction with matter are well understood, delivering them accu-
rately and safely to the desired target area in a patient still has considerable uncertainties.
Besides, the biological effectiveness of ion beams to tumor is not fully understood [9]. In
addition, the technology of particle therapy is too expensive at present. For example, the
cost of linear accelerator technology with proton therapy is higher in the order of 10-20
times more than photon therapy unit with the same technology. On the other hand, carbon
ion therapy unit is about 100 times more expensive than proton therapy unit. [9].
Figure 1.1: Typical depth dose characteristics of protons and photons in water [9].
1.1.2 Internal radiation therapy
1.1.2.1 Sealed source radiation therapy
Sealed source radiation therapy or so-called (brachytherapy) is a form of therapy per-
formed by positioning a sealed source emitting high dose or low dose rates of beta and/or
gamma radiation next to the desired tumor for a certain irradiation period. According to
the type and location of the tumor, the treatment uses either interstitial, intracavitary, or
surface application. The usage of brachytherapy gives the advantage of treating the tumor
with typically a lower integral dose to normal tissue than external radiation therapy. The
wide range of sources which can be used for this treatment (e.g. Cs137, Ir192, Au198, I125,
and Pd103) offers flexibility in choosing the appropriate radiation energy and half-time of
the radionuclide. Additionally, technical developments are in the direction of artificial
manipulation of sources sizes, shape and activity to fulfill the clinical requirement [8].
3
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1.1.2.2 Unsealed source radiation therapy
In contrast to sealed source radiation therapy, unsealed source radiation therapy is a
method where radioactive substances are injected (or ingested) to a patient in order to
target a specific organ using the chemical properties of the a tracer to which the radioac-
tive isotope is bound, and the behavior of the digestive and circular systems of the human
body. The method uses a similar concept as functional diagnostic imaging in nuclear
medicine but different types and quantities of radiopharmaceuticals. However, unsealed
source radiation therapy is confined to a few clinical usages or applications. (I131) used to
treat thyroid cancers and (Ra223, Sr89 or Sm153) used to treat bone metastases [8].
1.2 Linac-based radiation therapy techniques
Modern linacs in combination with auxiliary dose delivery systems provide different tech-
niques of external radiation therapy based on 3D anatomical information provided by CT
and/or PET and MRI. A description of the most common techniques, with focus on those
related to the thesis scope, is pointed out in the following.
1.2.1 Three-dimensional Conformal Radiation Therapy (3D-CRT)
3D-CRT is a treatment technique making use of several treatment projection angles and
complex fields defined by Multileaf collimator (MLC) to geometrically conform the ther-
apeutic dose as close as possible to the target volume based on ”forward treatment plan-
ning” method. Most treatments are delivered with a flattened beam (made uniform by the
use of flattening filters) and with uniform intensity across the field (within the flatness
specification limits). Physical and non-physical wedges or compensators are occasionally
used to modify the intensity profile to correct for contour irregularities of the human body
in order to produce more uniform dose distribution [8]. Figure 1.2 illustrates a typical
six-field technique to treat a prostate tumor case using 3D-CRT.
1.2.2 Intensity Modulated Radiation Therapy (IMRT)
IMRT is based on the delivery of several treatment fields that adapt the therapeutic dose
according to a modulation of the photon fluence. In addition to the use of different projec-
tion angles and different MLC fields than used in 3D-CRT, the dose can be more optimized
to the target volume utilizing a nonuniform intensity beam. Intensity modulation is per-
formed by MLC modulation in step-and-shoot (segmental) or sliding-window (dynamic)
fashions per projection angle. The planned fluence is electronically transmitted to the
synchronized MLC and linac for treatment delivery. A linac control system guarantees
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Figure 1.2: The upper left panel displays a six-field 3D beam arrangement for a prostate case
viewed along the superior-inferior axis. The upper right panel shows the uniform conformal dose
zones (red line) covering the tumor volume and prostate in the isocenter axial plane. Lower panel
displays a beam shaping relative to the contour of the tumor volume (solid light blue) and shielding
of of the rectum (brown wire cage) and bladder (yellow wire cage) [10].
the integration of treatment planning and delivery to ensure accurate and efficient data
transfer [11].
1.2.3 Volumetric Modulated Arc Therapy (VMAT)
VMAT is based on the delivery of a rotational cone beam with variable shape and beam
intensity. As an advanced form of IMRT, VMAT delivers the dose continuously as the
gantry rotates, leaves shift and dose rates change. The planner optimizes field shape
and beam intensities for a large number of projection angles, according to one or two
full gantry rotations. Unlike IMRT, the projection angles are not fixed, and the angular
resolution and rotational speed are dependent on the linac. However, the MLC movements
and the gantry rotation have to be synchronized to deliver the exact field shape at the exact
projection angle as planned. The large number of projection angles gives the advantage
of more conformal dose to the tumor and better sparing for organs at risk than the fewer
fixed projections used in IMRT. Moreover, VMAT is usually preferred to IMRT because of
superior delivery efficiency. The amount of saved time in comparison to other techniques
is dependent on the adopted system and the planning protocol of the specific clinic [12].
Typical dose distributions for the treatment of prostate tumor using the described three
techniques are illustrated in figure (1.3).
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1.2.4 Stereotactic Body Radiation Therapy (SBRT)
SBRT refers to a technique that uses ultrahigh doses and precise treatment fields to be
delivered in a lower number of fractions than conventional techniques. The higher dose
rate brings more fatality to the fast recovering tumor cells but requires additional measures
for dose conformation. For instance, the penumbra (fall-off) region around the radiation
field has to be well-defined to minimize the dose to normal tissue or more importantly
organs at risk. Accordingly, the dose delivery accuracy is of critical importance when
using this technique. Thus, the recommended tolerance level for SBRT is more restrictive
in comparison to other radiation therapy techniques [13].
(a)
c
(b)
(c)
Figure 1.3: Dose distributions for the treatment of prostate tumor using different techniques (a)
3D-CRT (b) IMRT and (c) VMAT (adopted from [12]).
1.3 Quality assurance for radiation therapy
”The purpose of a quality assurance program is the objective, systematic monitoring of
the quality and appropriateness of patient care. Such a program is essential for all activi-
ties in radiation oncology. The quality assurance program should be related to structure,
process and outcome, all of which can be measured. Structure includes the staff, equip-
ment, and facility. Process covers the pre- and post-treatment evaluations and the actual
treatment application. Outcome is documented by the frequency of accomplishing stated
objectives, usually tumor control, and by the frequency and seriousness of treatment-
induced sequelae” [14]. Thus, the quality assurance (QA) program in radiation therapy
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includes efforts from different disciplines. With reference to figure 1.4, each step requires
inputs either from the radiation oncologists, physicists, engineers or therapists. Although
medical physicists are more involved in the technical than medical aspects of QA, their
efforts substantially interplay with those of the other groups. In particular, the primary
task of medical physicists is to ensure the delivery of the planned dose to the patient with
an uncertainty inferior to 5% [15].
Uncertainties in treatment can be systematic and random. While the random errors cannot
be controlled, the systematic errors can be controllable if a comprehensive QA program
is conducted. In the framework of linac based radiation therapy, the program should be
able to catch errors of different origins including: (a) linac output, (b) patient image used
for treatment planning, (c) dose calculation in the patient image, (d) data transfer between
the TPS and the linac control system and (e) daily variations in patient positioning (e.g.
using inaccurate positioning lasers within treatment room). The rapid evolution of more
conformal dose delivery combined with the advancement in imaging techniques is adding
potential for improving the therapeutic ratio between tumor and normal tissue response.
However, the new advances have resulted in a recognized need for greater accuracy tests
in the radiation treatment process [16]. Thus, national and international organizations
provide local clinics with QA regulations and recommendations for these specific tech-
niques. Unfortunately, the regulations are general and usually cannot keep pace with
development in technology [10]. The lack of specific QA guidelines makes the clinics
develop their own protocols depending on in-house or commercial methods and detectors
[17]. Especially for delivery QA, the developed programs are focused on detecting IM-
RT/VMAT related errors which cannot be detected by conventional QA procedures used
for the conventional treatment techniques. Relevant aspects to tests for correct beam de-
livery include: accuracy and reproducibility of the MLC leaf positioning, measurements
of the inter- and intra-leaf leakage, leaf speed control, dose and dose rate linearity and
-specifically for VMAT- gantry rotational speed.
After having established these procedures, several clinics start to implement a pre-
treatment patient-specific QA for IMRT/VMAT plans in their practice. Implementation
of patient-specific pre-treatment QA proved to be crucial for treatment chain but needs
more investment in human resources and machine time [18]. Research communities are
working on optimization of QA tools to perform comprehensive tests more efficiently.
1.4 Rationale for EPID based dosimetry
Delivering the intended radiation dose to the patient is a complex process. The assurance
of the correct dose delivery needs equipment that accurately measures the dose with high
spatial and temporal resolutions. Additionally, in IMRT/VMAT techniques, a 3D dosime-
ter is desirable. The required features are not available in a single commercial device.
Thus, physicists use different dosimeters to satisfy these requirements. In practice, the
QA time efficiency is becoming an essential aspect of QA procedure. Optimizing the
set-up and processing time of current dosimetric methods without sacrificing the testing
7
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Figure 1.4: Steps in radiation therapy process and major uncertainties associated with each step
(adapted from [18]).
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quality is a goal. Hence, it is desirable to identify a dosimeter which is fast, accurate, 3D,
independent of TPS or delivery machine and sensitive to error dosimeter.
Electronic Portal Imaging Device (EPID) is a planar detector rigidly attached to modern
linacs with a primary function of 2D anatomical imaging of the patient prior to treatment.
It has been used for more than a decade for positioning verification. Prior to dose deliv-
ery, the oncologist checks the alignment of bony structures or other landmarks between
EPID images acquired on-site and reference images. The reference image is a digitally
reconstructed radiograph (DRR), which is a virtual radiograph generated by simulating
the X-ray transport into the patient CT and incident onto the detector plane [19].
Despite being used for imaging, EPID has been found as a candidate tool for QA. It
provides a relatively large detection area with a high spatial resolution. It requires no set-
up time and generates real-time images with sub-second temporal resolution which with
special computational approaches can be used to generate 3D dose distribution, as will be
discussed in chapter 3.
1.5 Thesis context and objective
The aim of this thesis is to develop a novel method to reconstruct a 3D dose distribution
using EPID technology for pre-treatment QA. The investigated 3D dosimetry is tailored
to IMRT/VMAT treatment plans. The dose reconstruction algorithm is implemented and
tested based on the equipment installed at the Department of Radiation Oncology of the
University Clinic of Munich (Klinikum der Universität München, Ludwig-Maximilians-
Universität). To illustrate the roadmap towards achievement of this goal, the content of the
thesis is divided into steps that span from the physics background of the EPID technology
to the performed experiments in the clinic.
In particular, chapter 2 explains the physics of photon and particle interactions with matter
and presents a theoretical description of the radiation detectors typically used in clinics
and the clinical X-ray generation among those techniques that are of interest for the the-
sis. Chapter 3 illustrates the technology of EPID and signal acquisition as well as image
processing. Chapter 4 presents the dosimetric characteristics of the EPID in comparison
to other dosimeters used in clinics followed by a complete literature review of the differ-
ent approaches to EPID dosimetry. Then, chapter 5 outlines the proposed novel method
for calibrating the EPID to produce a 2D dose distribution. The chapter then explains
the novel dose reconstruction method in chapter 6. The explanation includes a step by
step verification and result illustration. The overall accuracy in comparison to different
dosimetry methods is illustrated at the end of the chapter, with evaluation of IMRT/V-
MAT treatment plans of real clinical cases. Chapter 7 presents the tests of the sensitivity
of the proposed method detecting delivery errors along a description of the experiment
design and result. Chapter 8 is dedicated to discuss the findings and the potential usage of
the proposed dose reconstruction method with a comparison to other methods. The thesis
ends with a chapter giving the summary of the work and putting forward perspectives for
the development of radiation therapy QA.
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Chapter 2
Fundamentals of radiation therapy and
dosimetry
2.1 Interaction of radiation with matter
2.1.1 Interaction of photons with matter
In contrast to charged particle, photons are not detected by either electrical or magnetic
fields. Their electrical and magnetic properties are relevant to interaction with matter.
They can indirectly ionize the orbital electrons of the target atoms by undergoing vari-
ous possible interactions. Moreover, they can also directly ionize the atom by interacting
with the electrostatic field of the nucleus. The probability for each interaction depends
on the energy hν of the photon and the atomic number Z of the target. These interac-
tions could be categorized into five types: coherent (Rayleigh) scattering, photoelectric
effect, Compton effect, pair production and photonuclear disintegration. Since coherent
scattering and photonuclear disintegration occurs mainly in energies range ≤10 keV and
≥8 MeV respectively, these interactions are out of the energy used in this thesis (i.e. up
to 6 MeV). The other three interactions, as described in the following, have fundamental
roles in radiotherapy, imaging as well as radiation dosimetry.
2.1.1.1 Photoelectric effect
The photoelectric effect occurs when a photon is absorbed by an atom causing the ejection
of an orbital electron. As a condition in this effect, the photon energy is fully absorbed
by the atom. The kinetic energy equals the difference between the photon energy and
the electron binding energy. The ejected atomic electron creates a vacancy in the shell
causing an electron-ion pair and atomic instability. As a consequence, an electron from
an outer shell fills the vacancy with energy loss in the form of characteristic X-rays or
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Auger electrons. The interaction mechanism is schematically illustrated in (figure 2.1).
Figure 2.1: Diagram illustrating the photoelectric effect [8].
The interaction probability of the photoelectric effect has a complex dependence on the
medium and electron energy, In principle, The energy dependence of the cross section
is assumed to be = 1/E3 at low photon energies and gradually changes into 1/E at high
energies. Regarding atomic number dependence, the cross section is assumed to be Zn
where n ranges from 4 to 5 [20]. Figure 2.2 displays the atomic cross section for the
photoelectric effect against incident photon energy for various absorbers ranging from
Hydrogen to lead. The sharp spikes in all curves (except for H and C) indicate the absorp-
tion edges which correspond to the electron binding energies of the K-, L- and M- shells
of the absorbing material, showing that an incident photon with energy identical to one of
the absorption edge energies will experience a sudden increase in the photo absorption.
Accordingly, the maximum probability of a photoelectric effect occurs when low energy
photon interacts with a high Z material. In radiotherapy, the importance of the photo-
electric effect appears in transmission imaging for X-ray CT. For instance, bone (high Z)
absorbs more photons than soft tissue (low Z) resulting in image contrast.
2.1.1.2 Compton effect
In Compton effect, the incident photon collides inelastically with a free or loosely bound
electron. A fraction of the photon energy is transferred to electron kinetic energy whereas
the rest is preserved in the scattering photon (see figure 2.3). Practically, in Compton
effect, the incident photon has a much larger energy than the electron binding energy and
can assumably interact with a free electron, since it satisfies the energy and momentum
conservation principle. Accordingly, The scattered photon energy Es as a function of the
incident photon energy Ei and the scattering angle θ is calculated by:
Es =
Ei
1 +
Ei
mec2
(1− cos θ)
(2.1)
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Figure 2.2: Photoelectric atomic cross section against photon energy hν for various absorbers.
Energies of different absorption edges are also indicated [20].
where me is electron rest mass and c is the speed of light. For the recoil electron, the
sum of its kinetic energy Eke can be obtained depending on the conservation principle and
equation (2.1) as follows:
Eke = Ei − Es = Ei

Ei
mec2
(1− cos θ)
1 +
Ei
mec2
(1− cos θ)
 (2.2)
In the energy region not affected by electron binding effects, the atomic cross section
for Compton scattering aσc is determined from the electronic cross section eσc, which
is calculated by integrating the differential electronic cross section per unit solid angle,
using the relationship:
aσc = Z eσc (2.3)
As the eσc is given for free electrons and consequently independent of Z, the atomic cross
section aσc is linearly dependent on Z. Compton mass attenuation coefficient σc/ρ is
calculated from the aσc as follows:
σc/ρ =
NA
A a
σc (2.4)
where NA is Avogadro’s number and A is the mass number.
By using equation (2.3) in equation (2.3), σc/ρ is given by:
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Table 2.1: Compton atomic cross sections aσc and mass attenuation coefficients σc/ρ at photon
energy hν of 1 MeV for various absorbers [20].
Element Symbol Z A a
σc
(b/atom)
σ/ρ
(cm2/g)
Hydrogen H 1 1.01 0.21 0.1261
Carbon C 6 12.01 1.27 0.0636
Aluminum Al 13 26.98 2.75 0.0613
Copper Cu 29 63.54 6.12 0.0580
Lead Pb 82 207.20 17.32 0.0500
σc/ρ =
ZNA
A e
σc (2.5)
Since Z/A = 0.5 for low Z elements (except hydrogen) while increasing Z gradually
decreases Z/A to ≈ 0.4 for very high Z elements, the mass attenuation coefficient is
roughly independent of Z and proportional to the electron density (see table 2.1). For
instance, the Compton attenuation for constant energy per g/cm2 for bone is nearly the
same as that for soft tissue. Yet, 1 cm of bone would attenuate equivalent to 1.53 cm of
the soft tissue. This low difference in σc/ρ is a disadvantage in transmission imaging but
an advantage in therapy as the contribution to dose delivery of Compton scattering at the
same energy results uniform within different tissues.
Figure 2.3: Illustration of Compton scattering [8].
2.1.1.3 Pair production
When a photon with energy above 1.022 MeV interacts with the electromagnetic field
around the nucleus, its energy may be converted into electron and positron. Interestingly,
this photon to mass conversion process is an example of the famous Einstein’s theory
E = mc2. The photon energy exceeding the 1.022 MeV threshold is shared between the
particles as kinetic energy. The positron subsequently annihilates by combining with one
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electron of the medium close to its generation point, producing two annihilation photons
each with E = 0.511 MeV (fig 2.4). The annihilation is a reverse process of converting
mass to energy. The probability of pair production increases proportionally with Z2 and
increases as the logarithm of the incident photon energy above the threshold energy with
dominance over Compton interactions at energies above 10 MeV. Hence, the impact of
this interaction is minimal in therapy where the typical maximum energy is 6 MeV. In ad-
dition to pair production, a much less probable interaction could occur when the incident
photon has energy equal or higher than 2.044 MeV. In a process referred to as electronic
pair production or triplet production, the incident photon interacts with an orbital elec-
tron of the absorber resulting in the photon to disappear and three light charged particles
are released: the original orbital electron and the electron-positron pair produced in the
interaction.
Figure 2.4: Diagram illustrating the pair production in the nuclear Coulomb field [8].
2.1.1.4 Attenuation
Overall, photon attenuation when passing through matter is an exponential process as a
function of path length. Attenuation occurs either by absorption (e.g. photoelectric effect)
or scattering (e.g. Compton scattering). The attenuation is defined as the probability of
occurrence that the photon is removed from the beam per unit path length. The number
of transmitted photons I is described by Beer-Lambert’s law as follows:
I(x) = I0e
−µx (2.6)
Where I0 is the initial intensity (i.e. number of photons before attenuation), and x is the
path length of the absorbing material. µ is the linear attenuation coefficient in cm−1.
2.1.2 Interactions of charged particle radiation with matter
Charged particles are surrounded by the Coulomb electric field. When traversing an ab-
sorber, the particle may interact with the Coulomb electric field of the orbital electrons
or the atom nucleus resulting in elastic or inelastic scattering. The charged particle may
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transfer some of its kinetic energy to the medium (collision loss) or to photons (radiation
loss). However, the interaction type is depending on the mass of the charged particle and
the trajectory with respect to the absorber atom. The charged particles of interest in clini-
cal application can be either light (electrons and positrons) or heavy particles (protons and
helium, carbon and oxygen ions). General aspects of their interactions with the medium
are listed below.
2.1.2.1 Light charged particles
Light charged particles have a considerably smaller mass compared to the mass of atoms.
As for electrons with high energy, they experience radiative losses within Coulomb field
of nucleus and to less extent electrons. Low energetic electrons mainly experience ion-
ization/excitation with other electrons besides some Coulomb scattering. In the radiative
losses, the electron may undergo a significant loss of its energy accompanied by an emis-
sion of X-ray photons. This type of interaction is called bremsstrahlung and has the
major significance in X-ray generation in X-ray tubes and linacs, as discussed in section
2.3. Furthermore, the electrons may collide with an orbital electron causing electron ejec-
tion (atom ionization) or electron shell elevation (atom excitation). Overall, the electrons
experience multiple scattering when traversing through a media. The radiative yield, de-
fined as the average fraction of its energy that a beta particle radiates as bremsstrahlung
in slowing down completely, increases directly with the absorber atomic number Z and
the kinetic energy of electrons. In X-ray targets for imaging applications (energy around
100 keV), the radiation yield is of the order of 1%, whereas for radiation therapy (energy
in the range of 6-25 MeV) the radiation yield amounts to 10–20%.
As for positrons, they travel a small distance through the media and interact with sur-
rounded electrons through positron-electron annihilation mostly producing two 511 keV
photons.
2.1.2.2 Heavy charged particles
As ions have a mass considerably larger than electrons, they can be categorized as heavy
particles. Examples include protons, helium, carbon and oxygen ions. These particles
may undergo elastic and inelastic interactions with electron or nuclei similar to light par-
ticles but different in magnitude. As for heavy particles, they mostly interact inelastically
with electrons and do not change direction considerably when passing through a medium
due to their large masses. The heavy particles lose energy and slow down by ionizing or
exciting the orbital electrons. The slow traveling heavy particle has more probability of
inelastic interaction with Coulomb field of the nucleus. The rate of energy deposition per
unit path length is proportional to the square of the particle charge and inversely propor-
tional to the square of its velocity, according to the well known Bethe-Bloch formula [20].
That is the physical foundation of the Bragg peak, as maximal energy deposition close to
the range of the ion beam, and its use in particle external radiation therapy.
16
2.2. RADIATION DETECTOR PROPERTIES
2.2 Radiation detector properties
The primary function of radiation detection systems is to measure, either directly or indi-
rectly, the radiation quantity. Their basic principle is relying on the interaction of radia-
tion with the detector material. For detectors relying on ionization measurements, radia-
tion quantity is defined by the number of the charge carriers, either electron-ion pairs or
electron-hole pairs, created by the ionization process in the active region of the detector
volume. The average energy required to generate one electron-ion or electron-hole pair
is approximately constant (W ) with energy of the radiation and varies in dependence on
the detector type. For instance, W value ranges from 1 to 5 eV for semiconductor de-
tectors and ∼30 eV for gas detectors [21]. Consequently, the total number of the created
electron-ion or electron-hole pairs is proportional to the deposited radiation energy. Ac-
cordingly, the signal measured by the detector may be converted to absorbed dose with
special calibration and correction factors. As a radiation dosimeter, the detector must be
provided with adequate accuracy and precision, linearity with respect to the dosimetric
quantity, dose rate independence and the desired spatial resolution. Unfortunately, there
is no single dosimeter that can satisfy all these characteristics. Therefore, the choice of the
used dosimeter is highly dependent on the measurement purpose and requirements. In this
section, an overview of the different types of dosimeters used in conventional radiation
therapy is presented with particular focus on its advantages and disadvantages.
2.2.1 Ionization Chambers
The gold standard in accuracy and precision for radiotherapy dosimetry is the air filled
ionization chamber (IC). An ionization chamber is a gas-filled cavity having two parallel
collecting electrodes or one central electrode surrounded by a conductive outer wall. The
wall has different density but the same effective atomic number of the air to ensure similar
radiation interaction mechanisms to tissue. Although in principle the charge measured by
an air filled ionization chamber should be directly proportional to the adsorbed dose in
water the linearity is actually very sensitive to changes in temperature, pressure, humidity
and the applied voltage. As suggested by the IAEA in their code of practice and Ameri-
can Association of Physicists in Medicine (AAPM) [22] [23], a few corrections must be
considered. For example, calibrations are applied according to the following equation:
DQw = MkQN
60Co
D,w (2.7)
whereDQw is the absorbed dose in water for a certain “beam quality”Q, kQ is a conversion
factor specific for the chamber and the beam quality and N60CoD,w is the absorbed dose to
water calibration factor for the reference beam quality of 60Co while M is the corrected
charge measured by the ionization chamber through an electrometer and given by:
M = PionPTPPpolPelecMraw (2.8)
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where Pion corrects incomplete ion collection efficiency, PTP is the temperature–pressure
correction which corrects the reading to the standard environmental conditions for which
the ion chamber’s calibration factor applies, Ppol corrects for any polarity effects, Pelec
takes into account the electrometer’s calibration factor if the electrometer and ion chamber
are calibrated separately and Mraw is the raw ion chamber reading in Coulombs C.
Ionization chambers come in various shapes and sizes; the most widely used design is the
cylindrical “thimble” chamber due to its stability, accuracy and relative ease of use in clin-
ical environment. Figure (2.5), schematically illustrates the design of a typical cylindrical
chamber (i.e. Farmer chamber). However, when measurements of strong radiation field
gradients are required, Farmer chambers do not represent the elective choice due to large
effective volume (of about 0.60 cm3) and low spatial resolution. Thus, different chamber
models with smaller sizes are used in this case.
Different from cylindrical chambers, the parallel plate ionization chamber has a flat plane
(toward the radiation source) making the point of measurement at the front surface of the
cavity. The parallel plate ionization chambers also have a fundamental role in radiother-
apy as they represent the monitoring systems of the linear accelerators (see section 2.3).
Figure 2.5: Basic design of a cylindrical Farmer graphite/aluminum chamber. Nominal air vol-
ume, 0.6 mL [8].
2.2.2 Diode Detectors
Diode detectors consist of semiconductor silicon crystal doped with different impurities
on the two sides. The N-type side is the electron rich region while the P-type side is
the hole rich region. Applying voltage upon these two sides creates a depletion region
which may act as the air cavity of ionization chambers. The ionizing radiation generates
electrons (free charge carriers) and holes when passing through the depletion region. The
electrons move towards the P-type region and create an electric current that can be mea-
sured with high precision. The average ionization energy needed to form an electron-hole
pair in silicon is around 3 eV whereas the ionization energy for ICs is about 30 eV. This
feature in combination with the crystal density, about 1800 times denser than air, leads to
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a relative efficiency per unit of volume four orders of magnitude larger than ICs. Thanks
to the relatively small size of these detectors, the construction of high spatial resolution
dosimeter is enabled. However, these detectors exhibit angular dependence. Thus, the
detector orientation during measurements has to match the calibration orientation. Fur-
thermore, the diodes are made of a non-tissue equivalent material and due to that, these
detectors are highly energy dependent. These drawbacks make the diodes suitable for
high resolution relative dosimetry, but not for absolute dosimetry. The calibration should
be as a function of the beam energy with specific correction factors for field size, physi-
cal attenuators, projection angle, source to surface distance and temperature. The diodes
are commercially available in forms of single diodes, 2D array, and 3D array (see 2.6).
Diodes are used for routine QA programs and even dose measurement during treatment
(in vivo dosimetry).
Figure 2.6: Sun Nuclear R© diodes in different forms: (a) single, (b) 2D array and (c) 3D array.
2.2.3 Diamond Detectors
The diamond detectors are classified as semiconductor detectors made of diamonds syn-
thetically produced in laboratory through the process of Chemical Vapor Deposition
(CVD). Due to a relatively large ionization energy of 5.54 eV compared to semicon-
ductor silicon crystal, the free charge carriers are less and hence, diamond detectors offer
higher resistivity and correspondingly lower leakage currents with respect to diode detec-
tors. Furthermore, the incident radiation interacts with the active region of the detector
creating electron-hole pairs without being depleted. A current is generated and measured
using an electrical field across the detector contacts. The signal is then linearly ampli-
fied, thus making it proportional to the induced charge. Commercially, these detectors
are manufactured with a very small sensitive volume in the order of a few mm3 with high
sensitivity, resistance to radiation damage and encapsulated in a waterproof isolator (see
2.7).
Diamond detectors are tissue equivalent, have no energy dependence, have small sensi-
tive volume (and thus, high spatial resolution) and have no strong angular dependency.
This gives the diamond detectors the merits to be used in radiotherapy clinics as an abso-
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lute dosimeter for regular measurements and exclusively for high dose gradient and small
fields. However, diamond detectors have a relatively high cost due to the scarcity of high
quality material making their use in common practice limited [24].
Figure 2.7: (a) Sketch of a diamond based detector [25]. (b) PTW R© micro-diamond detector.
2.2.4 Films
Films could serve in diagnostic radiology, radiation therapy, and radiation protection. For
films dosimetry, radiographic or radiochromic films can be used. The former type once
was the cornerstone of detection systems in transmission imaging and was used also in
relative dosimetry. However, nowadays, it is replaced by digital detectors for imaging
purposes and radiochromic films for dosi3metry. Radiochromic films are colorless films
with tissue equivalent composition. The commonly used type is the GafChromic film with
active layer of a thickness = 30 µm [26] (figure 2.8). When ionizing radiation interacts
with the active layer, the dye of the film polymerizes and develops a different color. A
laser scanner is used to produce a (Red, Green, Blue) colored image out of the irradiated
film. The degree of coloring in the each channel is expressed in optical density (OD) and
defined as:
netOD = ODirradiated −ODunirradiated = −log10PV Rirradiated/PV Runirradiated (2.9)
where (PV R) is the raw pixel value typically from the correspondent color channel. The
relationship between the (OD) and the dose (D) is expressed by:
D = A0 × netOD + A1 × netODA2 (2.10)
where Ai (i = 0...2) are the fitting parameters. The calibrated radiochromic films per-
form relative or absolute dosimetry with sub-millimeter spatial resolution and accuracy
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in dose determination ±3% with even better results when using a more complex triple
channel [26]. Although the self-developing radiochromic films are easier to use than the
radiographic films (e.g. no need for dark room, film cassettes or film chemical process-
ing), radiochromic films are still categorized as passive dosimeters and could not provide
a real-time measurement. However, these films are used in radiotherapy clinics in IM-
RT/VMAT pre-treatment QA programs due to their superior spatial resolution over other
dosimeters.
Figure 2.8: (a) Picture of cutted GafChromic films irradiated with different doses. (b) Scanned
images of correspondent films. The images represent the pixel values in the red channel.
2.2.5 Thermoluminescent detectors
Thermoluminescent detectors (TLD) used in medical applications is almost composite of
tissue equivalent crystalline materials (e.g. lithium fluoride doped with magnesium and
titanium, LiF: Mg, Ti). When ionizing radiation interacts with the crystal lattice, orbital
electrons are excited to a higher state, but instead of subsequently relaxing to the ground
state, they remain trapped in the so-called “electron trap” made by the lattice impurities
(usually magnesium or titanium). The electron cannot escape the trap at room temperature
and therefore, the charge is stored till the entrapment process of heating the crystal is
applied. The electrons lose the excitation energy as visible light, which is converted to
electrical current by a photomultiplier and subsequently measured. The measured signal
is then calibrated to dose. TLD is meant for measuring a cumulative dose. However,
the crystal reaches the saturation once all traps are occupied by electrons. Though, the
heating process clears electrons traps and the TLD is then annealed and may be reused
for dosimetry.
TLDs are commercially available in various forms (e.g. powder, chips, rods and ribbons).
Due to their small sizes and no need of connecting wires, they are used in radiotherapy
either in routine QA procedure, in-vivo dosimetry or implanted in phantoms. TLDs are
also used as personal dosimeters for radiation workers.
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Figure 2.9: (a) A simplified energy-level diagram illustrating the thermoluminescence process
[8]. (b) Different shapes of TLDs.
2.2.6 Polymer Gels
Polymer gels are composed of radiosensitive chemicals dissolved in gelatin. In brief,
when irradiated, the chemicals polymerize forming free radicals that can be quantified
by measuring the changes of nuclear magnetic resonance spin-relaxation time using an
MRI scanner, or estimating the density changes using typically optical or X-ray CT or
ultrasound. Polymer gels can be molded to any desired shape or form, and since the gel
is approximately tissue equivalent, they can be used as phantoms (figure 2.10). Conse-
quently, gel dosimetry is the only 3D dosimetry system, providing a 3D dose distribution
with high spatial resolution.
Polymer gel dosimetry proved its usefulness for dose verification in IMRT/VMAT [27].
However, similar to film dosimetry, polymer gels are designed for single measurements,
and as passive dosimetry systems, they require long processing time and sophisticated
readout systems.
2.3 Clinical linac
Linac is a device that accelerates charged particles (electrons) using high-frequency elec-
tromagnetic waves in a linear tube. The medical linac accelerates electrons to a nominal
energy that ranges from 6 to 25 MeV. Accelerated electrons can be used to treat superfi-
cial tumors or to strike a target to produce X-rays for treating deep seated tumors. The
modern linac components are illustrated in figure 2.11. The working principle of the sys-
tem is described in the following. First, the electrons are generated in the electron gun by
thermoionic emissions from a hot tungsten filament (cathode) and guided by the anode
towards the waveguide tube. In the waveguide tube, high pulse microwaves produced by
a magnetron or a klystron accelerate the electrons to velocity comparable to the speed of
light. The strong magnetic field inside the tube focuses the electrons in a pencil beam
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Figure 2.10: (a) Polymer gel dosimeter irradiated according to 3D-CRT techniques. (b) The upper
left picture illustrates the irradiation effect (white region) on the dosimeter. The rest; different
views of the dose distribution obtained by use of MRI scanner [18].
with a diameter of about 2 mm. The pencil beam is bent across the bending magnet to
perpendicularly strike a high Z target. Bremsstrahlung X-rays are produced by the inter-
action between the electron beam and the target with a spectrum of energies from 0 up
to the nominal (maximal) energy of the incident electrons. Due to the high energy of the
electrons, the X-ray beam produced in the target is mainly peaked forward in the beam
direction. The process of shaping the photon beam starts in a component of the linac
called head. Although the compositions and elements of the linac head are specific to
manufacturer, the general scheme mainly consists of a flatting filter, monitoring chambers
and three collimators (i.e. primary, secondary and the multi-leaf collimator (MLC)). The
generated photons are collimated by the primary collimator and their intensity is made
fairly uniform by the flattening filter. The beam is controlled and monitored by a monitor
chamber (parallel plate ionization chamber) located immediately after the flattening filter.
The secondary collimator placed after the flattening filter is movable and used to define
the rectangular field shape with two upper and two lower independent jaws. In mod-
ern linacs this function is embedded in the MLC and the four jaws are replaced by two
guardian jaws (diaphragm) placed downstream the MLC. The MLC is an array of high
Z leaves that can be individually controlled to create regular and irregular beam shapes.
Modern linacs incorporate up to 160 leaves with 5 mm width creating fields up to 40 ×
40 cm2 (figure 2.12). Dose delivery techniques based on MLC (e.g. VMAT) set techno-
logical challenges requiring high precision of leaf positions with high-speed movement
of the MLC. In addition, to modulate the intensity of the beam, the MLC and the rigidly
attached diaphragm can rotate around a vertical axis and the linac head is mounted on
a gantry that can rotate around the patient in the longitudinal axis. Additionally, leak-
age of radiation through the MLCs (known as intraleaf and interleaf transmission) adds
extra dose to the patient. In order to minimize this effect, leaves are designed to have
stair-step leaf-sides, and adjacent leaves interlock in a ‘tongue-and-groove’ arrangement.
Even more, the leaves edges in the beam direction contribute to the dose distribution and
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field penumbra. The leaf thickness along the beam direction ranges from 6 cm to 9 cm,
depending on the type of accelerator [7].
Figure 2.11: Schematic diagram of a medical linear accelerator [20].
2.4 Quantification and Measurement of Dose
Quantification of radiation deposition in the human body is essential for any medical use
of radiation. All radiation dosimetry systems are designed to represent the energy deposi-
tion to the human body either by directly or indirectly ionizing radiations. In the medical
field, dosimeters are used for diagnosis, treatment or protection of patients, workers, and
the public. The goal in transmission imaging is to obtain the maximal image quality with
the lowest radiation dose. In radiotherapy instead, the best compromise between the ther-
apeutic dose to the tumor and the unwanted dose to normal tissue is searched. In radiation
protection, the radiation exposure is minimized according to the principle of As Low
As Reasonably Achievable (ALARA) for all the involved people. Depending on the spe-
cific applications, several quantities and units have been introduced to describe dosimetric
quantities. The dosimetric quantities of interest for the thesis work are described.
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Figure 2.12: (a) A schematic side and front views of a single leaf of Agility R© MLC [28]. (b)
Beam’s eye view of a field modulated using MLC [29]. (c) and (d) Different pictures of an
Agility R© MLC illustrating 160-leaf arrangement.
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2.4.1 Photon fluence and energy fluence
The particle fluence (Φ) is defined as the number of particles (dN ) incident on a sphere
of cross-sectional area (dA):
Φ =
dN
dA
(2.11)
The International System of Units (SI) unit of particle fluence is m−2. The energy fluence
(Ψ) is defined as the radiant energy (dE) incident on a sphere of cross-sectional area (dA):
Ψ =
dE
dA
(2.12)
The SI unit of energy fluence is J/m2. The relation between energy fluence and photon
fluence for a monoenergetic beam is given by:
Ψ =
dN
dA
E = ΦE (2.13)
2.4.2 Exposure
The exposure (X) is the absolute value of the total charge of the ions (dQ) of one sign
produced in air when all the electrons and positrons liberated by photons in air of mass
(dm) are completely stopped in air.
X =
dQ
dm
(2.14)
The unit of the exposure is typically roentgen (R) which is equivalent to a charge of
2.58× 10−4 C produced per kilogram of air in SI unit.
2.4.3 Kerma
The Kerma (K) is an acronym for kinetic energy released in the medium and it is defined
as the as the expectation value of the energy transferred (dEtr) form the indirectly ionizing
radiation (photons or neutrons) to charged particles per unit of mass of the absorber (dm):
K =
dEtr
dm
(2.15)
The SI unit of Kerma is (Gy) which equals 1 Joule of energy transferred per kilogram of
a medium.
In reference to energy transfer method, Kerma can be divided into two components: the
collision kerma Kcol and the radiative kerma Krad. Kcol refers to the energy transfer re-
sulted from Coulomb force interactions with atomic electrons. Thus, Kcol leads to the
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production of electrons that dissipate their energy as ionization in or near the electron
tracks in the medium. Krad refers to the energy transfer resulted from radiative interac-
tions (bremsstrahlung and less-likely electron-positron annihilation). Thus, Krad leads
to the production of radiative photons that transfer a fraction of the energy out of the
medium.
2.4.4 Dose
The Dose (D) is defined as the expectation value of the absorbed energy (dε) per unit of
mass of a medium (dm). Unlike Kerma, dose applies to the expectation value of both
indirectly and directly ionizing radiations:
D =
dε
dm
(2.16)
Similar to Kerma, the SI unit of the absorbed dose is (Gy).
2.4.5 Charged Particle Equilibrium
The energy transfer from the photon beam to the charged particles (Kerma) at a partic-
ular location does not lead in principle to a dose deposition at the same location. The
secondary electrons move away according to their range in any direction and can escape
the location of interest. Thus, given a certain photon fluence, the Kerma is easily esti-
mated but not the dose. In a homogeneous medium, Kerma is maximal at the entrance
of the medium, while the absorbed dose initially builds up as a function of depth until a
maximum dose is reached (Zmax) (figure 2.13). Where the two curves meet, the charged
particle equilibrium (CPE) is reached. Then, at depths greater than the maximum depth
(Zmax), there is a transient charged particle equilibrium (TCPE) in which bothD andKcol
decreases at the same rate. Thus, the absorbed doseD to a medium can be calculated from
the energy fluence (Ψ) following the following equation:
D = βΨ(µen/ρ) (2.17)
where (µen/ρ) is the mean mass energy absorption coefficient and β is the quotient of D
at a given point and Kcol at the same point. β is < 1 at the build-up region, = 1 at the CPE
point and > 1 at the TCPE region.
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Figure 2.13: Kerma Kcol and absorbed dose D as a function of depth in a homogeneous medium
irradiated by high energy photon beam for (a) the hypothetical case of no photon attenuation and
for (b) realistic case adapted from [15].
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2.5 Dosimetry of Photon Beams
2.5.1 Characteristics of Photon Beams
In radiation therapy, photon beams generated by the linac are polyenergetic and have a
wide distribution in energy that spans from 0 eV to the nominal energy of the accelerated
electrons. The shape of the spectra depends on the shape of the electron beam energy,
the target (photon source) thickness, the fixed collimators (used for shielding), flattening
filter and movable collimators (jaws, MLC, diaphragm ...). Particularly, the movable
collimators (i.e. jaws, MLC and diaphragm) are those determining the field shape that
changes the energy distribution of the machine specific reference field to variable standard
fields. Different spectra for different energies generated by Monte Carlo simulation [30]
are illustrated in 2.14
Figure 2.14: Comparison of MC calculated spectra for different commercial linacs [30].
The energy distribution is the most exhaustive description of the photon beam quality
but difficult to measure. Typically, the beam quality is indirectly assessed by measuring
the percentage dose as a function of depth and lateral dose profile in a water phantom.
This assessment is incomplete, but sufficient for operation of treatment routine. However,
recently, some clinics uses a comprehensive characterization of beam quality in order to
improve the dose calculation accuracy.
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2.5.2 Dosimetric measurements used to characterize the photon
beam
The attenuation of a photon beam traversing air is negligible and the intensity due to di-
vergence can be determined using the inverse square law. When traversing media with
varying density, on the other hand, the photon beam undergoes attenuations which are
more complicated to calculate. Therefore, various dosimetric quantities and methodolo-
gies have been introduced to facilitate dose calculation in radiation therapy situations.
The dosimetric measurement is usually performed in a water phantom due to its similar
absorption and scattering properties of muscle and other soft tissues. For practical rea-
sons, the dosimeters and also preferred to be made of water or tissue equivalent material
in terms of response to Compton effect (the most predominant interactions in photon ther-
apy energy range). Hence, the given material must have the same electron density as that
of water. With reference to the dosimetry of photon beams in water, additional dosimetric
quantities of interest to the thesis objectives are described below.
Depth dose distribution
As the photon beam propagates through a water medium, the dose deposition varies per
depth in dependence of the beam energy, depth, and distance from the source. Therefore,
measurements of the central axis dose distribution for different field sizes provide a good
beam characterization method. Percent Depth Dose (PDD) is a quantity used for beam
characterization and obtained by measuring the absorbed dose at any depth Z divided by
the absorbed dose at a reference depth Zmax along the central axis of the beam, thus:
PDD =
Z
Zmax
× 100% (2.18)
In practice, PDD is measured for different nominal energies and different rectangular field
sizes during linac commissioning. The commissioning data are then used as a benchmark
for future QA measurements.
Linac output
The linac output is defined as the variation of the absorbed dose at Zmax as a function of
the field size in water. Multiple factors were shown to affect the output factor. Namely, the
Scattered photon from the linac head structure, backscattered photons, and electrons into
the monitor chamber and, at very small filed sizes, the effect of X-ray source obscured
by the collimator [31]. Accordingly, the output is considerably differed from one type of
linac to another. As a necessary procedure in linac commissioning and periodic QA, the
output factor of each representative field size is measured for each available energy. The
measured output is referred to a selected standard field size (commonly the 10 × 10 cm2
field) at the distance from the source to the axis of gantry rotation known as the iso-center.
Field size and shape play a significant role in determining the PDD curve. In general,
as the field size increases, the contribution of scattered photons to the absorbed dose
increments (figure 2.15). On the other hand, the variation of energy distribution inside
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a medium influences the responses of detectors especially the highly energy-dependent
ones. Hence, accurate estimation of the output is required in order to accurately correct
for energy over or under response of detectors for different squared field sizes.
Figure 2.15: Scatter radiation increases with field size.
However, in clinical practice, the majority of the treatments fields are irregularly shaped
(not squared). in such scenarios, accurate determination of the output factor is challeng-
ing. Thus, a rule-of-thumb method of equivalent squared fields to different field dimen-
sions and shapes has been developed and proved to be useful for quick calculation of the
equivalent field parameters [32].
Beam lateral profiles and off-Axis ratio (OAR)
The off-axis-ratio (OAR) between the dose at an off-axis point, either in the cross-line (x
direction) and in-line (y direction) directions, and the dose on the central beam axis for
any given depth provides a 2D information on the dose distribution inside the phantom.
This measurement is performed in QA programs to assess the beam flatness and the beam
symmetry, which are relevant also for dose calculations. Beam lateral profiles consist of
three regions: central, penumbra and umbra. The central region represents the portion of
the beam including doses over 80% of the maximum dose. The penumbra represents the
fall-off area at the beam edges. Specifically, the penumbra region is the part of the dose
that lies within 20-80% (or sometimes 10-90%) of the maximum dose. The size of the
penumbra is geometrically determined by the focal spot of the photon beam (source shape
and size) (figure 2.16a), the field size, the MLC shape (figure 2.16b) and the lateral elec-
tronic disequilibrium due to Compton scattering. The umbra is where the doses are below
the 20% (10%) of the maximum dose. These low doses result from radiation transmitted
through collimators and scattered radiation from the linac head shielding.
2.5.3 Dosimetry of photon beams in a patient
Unfortunately, dose calculation in water does not apply to the patient since the patient
tissues are not perfectly water equivalent and the patient surface is not entirely flat. The
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Figure 2.16: (a) The penumbra appears as blurring of the field edge (yellow) and it is directly
proportional to the physical size of the source. (b) The penumbra depends also on the MLC tip
shape [33].
beam traverses inhomogeneities so that high density tissues (e.g. bone) increase the at-
tenuation whereas low density tissues (e.g. lung) decrease the attenuation. To account for
this, complex models are needed thus making dose calculation in inhomogeneous media
a complicated task. Therefore, water dosimetry is adequate to characterize the radiation
beam but not sufficient to calculate the deposited dose into a patient.
2.6 Treatment planning systems and dose calculation
Current radiation therapy techniques require sophisticated systems to encompass and con-
trol the entire clinical work-flow of the treatment. The Treatment Planning System (TPS)
represents the heart of that systems and the first key to ensure an accurate dose deliv-
ery. In principle, the TPS is responsible for importing the patient CT and PET or MRI
images. The tumor and organs at risk delineation and contouring occur within the TPS.
According to the tumor location, size and organ at risk constraints, the oncologists along
with the physicists (dosimetrists in a few clinics) define the setting parameters relevant
to the chosen radiation therapy techniques, for example, the projection angles for IM-
RT/VMAT. The settings are given as input to the TPS by the operators. In accordance
to the setting parameters, the treatment parameters (including leaf sequencing for fluence
modulation in IMRT/VMAT) that optimize the planned therapeutic dose are calculated
by the TPS. The treatment parameters are determined by “inverse planning”. Briefly, the
planner calculates the 3D dose distribution relying on a virtual therapy simulation hav-
ing as input the patient image provided with the contours of the target volume and the
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organs at risk as well as the planning aims (dose prescription, ...). After this calculation, a
quantitative assessment of the dose distribution for a set of control points are evaluated to
check if dosimetric constraints are met. If not, the TPS iteratively optimizes the treatment
parameters by changing them until a clinically acceptable dose is achieved. Figure 2.17
illustrates schematically the process of radiotherapy planning cycle.
 
Image acquisition
Definition of tumour,
target volume and
organs at risk 
Dose calculation
Evaluation of 
dose distribution
Patient treatmentDefinition of treatment parameters
Virtual therapy simulation
Optimization
Figure 2.17: Radiotherapy planning cycle [7].
As the dose calculation and evaluation are of concern for this thesis, more detailed infor-
mation about those processes is in the following.
2.6.1 Approaches to dose calculation
The calculation of 3D dose distributions within the patient is a cornerstone procedure in
radiotherapy. The calculation has to satisfy speed and accuracy requirements for clinical
implementation. Originally, doses have been calculated using correction factors applied
to dose calculation in water to account for irregularities in surface contour and inhomo-
geneities in tissue. With the increasing complexity of the treatments, this method was
replaced by more sophisticated model-based or Monte Carlo dose calculation engines. A
brief overview of the predominant dose calculation algorithms used currently in radio-
therapy clinics is outlined.
2.6.1.1 Model-based dose calculation engines
In general, most of the model-based methods use convolution kernels that have been pre-
computed using Monte Carlo simulations. The algorithms differ in modeling method-
ologies and the magnitude of approximations used to speed up the calculation. Different
calculation methods are described:
Pencil beam (PB)
PB is a model-based dose calculation method based on beamlets (pencil beams) gener-
ated from predefined energy fluences. The photon beam is therefore assumed as a linear
combination of beamlets. The interaction point of the beamlet is assumed to lay on its
central axis and the dose deposition in water is defined for each beamlet which is derived
from the measured beam data. Here, inhomogeneities are accounted for by scaling the
33
CHAPTER 2. FUNDAMENTALS OF RADIATION THERAPY AND DOSIMETRY
path length of the dose kernel in water to any tissue according to the relative electron
density differences along the beamlet penetration depth. The scaled path length is called
radiological length and it is used to calculate the Total Energy Release per unit MAss
(TERMA) along the central axis of the PB. TERMA can be calculated using the formula:
TERMA = (µtotal/ρ)Ψpr (2.19)
where (µtotal/ρ) is the mass attenuation coefficient and Ψpr is the primary photon energy
fluence. Consequently, the dose D~r is the product of TERMA T~r and the dose kernel
A(~r-~r ′), which is the dose matrix generated per unit terma, integrated (i.e. equivalent to
a convolution) over a volume:
D~r =
∫
T~r ′A(~r − ~r
′
)d3~r
′
(2.20)
Collapsed Cone
Similar to the PB method, the collapsed cone method uses a convolution between TERMA
and the dose deposition kernel. However, the kernel is represented analytically and ex-
pressed in polar coordinates. The collapsed cone is based on point spread convolution
kernels to be collapsed into a certain number of photon rays of different directions to save
considerable calculation time.
Analytical anisotropic algorithm (AAA)
The analytical anisotropic algorithm is based on the pencil beam convolution technique.
Different from PB, AAA uses separate models for primary photons, scattered photons,
and the fundamental secondary electrons. The radiological length in this case is also used
to account for the electron densities in lateral directions. The total doses are obtained by
superposing the doses from the photon and electron convolutions.
These models have been extensively tested and compared by several scientific groups [34]
[35] [36] [37] [38].
2.6.1.2 Monte Carlo (MC) dose calculation engines
MC simulation methods are based on computational algorithms that utilizes random sam-
pling of physical event probabilities to numerically describe radiation transport. The
probabilities for any kind of interaction between the particle and the media rely on fun-
damental laws of physics or experimentally determined cross sections. The transport of
a primary particle is called history. Hence, the number of projected particles determines
the accuracy of the MC simulation. It has been estimated that 109 events are required
to achieve adequate precision of a Monte Carlo simulation for dose calculation in radio-
therapy [18]. To achieve the desired accuracy, the MC simulation has to include com-
prehensive modeling of the electron beam, linac head, patient anatomy and surrounding
objects. Comprehensive modeling is computationally expensive and may require access
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to unavailable confidential information from the manufacturer, as a consequence, it does
not match requirements for clinical routine. The MC dose calculation is the most accurate
method to determine the dose distribution in inhomogeneous media. Separately, general
purpose codes such as EGS4/EGSnrc [39], Penelope [40], MCNP [41], and GEANT4
[42] have been developed for simulating the transport of electron and photons. As these
codes have incorporated specialized features, they have been optimized for radiation ther-
apy proposes. The optimizations include avoiding the full simulation of the treatment
head by replacing primary histories with pre-defined phase space or virtual source mod-
els [43] [44] [45]. Additionally, these codes are optimized for calculating the dose within
the patient, relying on tissue compositions mapped from the CT image and using energy
cut-offs satisfying clinical significance. As a result, the optimization reduces the calcu-
lation time down to minutes (instead of hours). Examples of these MC dose calculation
engines are Voxel Monte Carlo [46] and Dose Planning Methods (DPM) [47]. Commer-
cially, optimized MC dose calculation engines have been recently provided by ELEKTA
(Monaco R©), Varian (Eclipse R©), Brain Lab (iPlan R©). A comprehensive comparison be-
tween the full Monte Carlo simulation and the optimized one has been published in [48]
[49].
2.7 Quantitative assessment of dose distributions
Since the advent of IMRT techniques, it has become standard practice to verify the de-
livery of IMRT plans using either direct measurement of radiation dose distribution in a
phantom [50] [51], or indirect methods that compare the TPS calculation with an indepen-
dent computer calculation [52] [53]. Both verification methods require a comparison tool
to quantify the difference between the two dose distributions. Such comparison is subject
to several challenges that make the extraction of clinically significant results difficult. The
complexity of comparison increases with the dimensionality of distributions being evalu-
ated. For instance, simple single points (0D) comparison is conducted by calculating the
mathematical difference of the reference and the measurement in terms of absolute or rel-
ative doses, depending on the situation. The interpretation is straightforward (assuming
the data are well coregistered) and a certain threshold can be used to make the clinical
decision on accepting or rejecting the result. On the other hand, although the difference
between corresponding points of one dimensional (1D) dose profiles can be easily cal-
culated, the 1D comparison results in problematic interpretation of the differences. For
example, dose differences could be small in the regions of uniform dose and large in high
gradient regions where the alignment of profiles is not perfect. The large difference may
or may not be of clinical significance depending on the location in the patient anatomy.
This dilemma prevents the use of a single threshold value to accept of reject the result.
Additionally, as the dimensionality of dose distribution increases (2D, 3D, 4D), the in-
terpretation of results in the presence of local dose gradients becomes more complex. To
handle these complications, different approaches have been introduced to qualitatively
and quantitatively compare the dose distributions.
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2.7.1 Qualitative comparison methods
Visual inspection of the dose distribution is commonly used in clinics [18]. The main
advantage of this qualitative inspection is the fast identification of the major differences
between the dose distributions. In practice, several evaluation software packages view
the two dose distributions, within the same patient CT, side by side with highlighted
dose differences. Other software packages display the dose level contours of the two
distributions within the patient CT on one figure. For both display formats, in addition
of failing to catch differences in the order of 3-5%, this comparison method leads to
interpersonal variability in the interpretation [54]. Thus, a quantitative method is required
to support the safety net for the radiotherapy chain.
2.7.2 Quantitative comparison methods
The quantitative comparison is based on calculating the difference of the dose distribution
with respect to a reference one. Assuming that the two distributions are coregistered,
the comparison can include the relationship between dose level and geometry. In the
following, a description of the most used methods in modern clinics is presented.
2.7.2.1 Dose Volume Histogram (DVH)
DVH is a representation of dose distribution within a particular volume of interest (VOI)
by means of the frequency distribution of variable dose within the volume. DVH can
be defined as differential and cumulative. The differential DVH indicates the volume
of a certain structure that receives the dose corresponding to the bin, ranging from the
minimum to the maximum dose. Differential DVH provides information about changes
in dose within the considered structure and easily visualizes minimum and maximum
dose. A cumulative DVH represents the volume of a certain structure that at least receives
the dose corresponding to the bin. In other words, cumulative DVH is a plot of dose bins
receiving a dose equal to or greater than the indicated dose as a function of volume (or
percentage volume). The construction of both types of histograms is outlined in figure
(2.18)
Generating a DVH for each dose distribution for which underlying structures exist may
help the user to evaluate the quality of the plan and when comparing to a measurement,
the user may appraise the contribution of the dose differences to the tumor and organs
at risk. However, the accuracy of the DVH curves relies on the accuracy of the dose
calculation algorithm, choice of grid spacing, volume delineation limited by the observer
bias and imaging resolution [55] [56]. Accordingly, DVHs should always be inspected
in conjunction with graphical representations of the dose distributions [57]. A practical
comparison of DVH distributions with the aid of 3D viewing of the dose distribution is
shown in figure (2.19).
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Figure 2.18: Illustration of (a) differential DVH and (b) cumulative DVH. Source: Tony Lomax,
PSI, CH.
Figure 2.19: Dose distribution of a plan of prostate case showing (a) axial view (b) DVH of
doses to the prescribed planning dose volume (PTV), bladder, rectum, left (LFH) and right (RFH)
femoral head (c) coronal view (d) sagittal view [58].
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2.7.2.2 Gamma analysis
The gamma evaluation is a tool utilizing the criteria of geometric distance to agreement
(DTA) and a percentage dose difference (DD) to calculate a gamma index with respect to
the reference for each pixel/voxel in an image/volume. Gamma evaluation aims at find-
ing the shortest Euclidean distance between a given point in the reference dataset and the
compared dataset in terms of DD and DTA. DTA and DD criteria permit small disagree-
ments between the doses of varying geometric extent and magnitude with reference to
dedicated tolerance limits. To calculate the gamma index, a point is taken in the reference
dose (RD) and compared to all points in the evaluated dose (ED) distribution in term of
DTA and DD. The point in the ED with the lowest gamma index is considered the best
match. The search for the best match is limited in a geometrical region of interest (ROI)
around the given point in the RD. The gamma index (γ) for a reference point pr in the RD
can be calculated using the equation:
γ(pr) = min{
√
∆d2pr,pe
DTA2
+
∆D2pr,pe
DD2
}∀{pe ∈ υ̇} (2.21)
Where pe is any point within the search circle or sphere υ̇ of a radius (ROI) in the ED (see
figure 2.20). ∆dpr,pe and Dpr,pe are the geometrical distance and dose difference between
points pr and pe respectively. Pixels (in 2D evaluation) or voxels (in 3D evaluation) with
|γ| > 1 fail the comparison for the given criteria [59]. Typical tolerance criteria used in
IMRT are DD = 3% and DTA = 3 mm [18]. The overall evaluation of the comparison is
usually estimated by the result of the percentage of passing pixels/voxels.
Figure 2.20: Illustration of (a) the circular search region for 2D evaluation and (b) the spherical
search region for the 3D evaluation [59].
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2.8 Rationale for patient specific pre-treatment QA
As illustrated in the previous sections, dose delivery becomes more complicated with
the development of technology. Unfortunately, the complexity adds potential sources
of errors, and hence, end-to-end patient management is prone to uncertainty. Interna-
tional and national organizations legislate a series of QA programs to be enforced in
radiotherapy clinics. In principle, the primary goal of the overall program is to ensure
the correct diagnosis of cancer, the optimum treatment plan, accurate dose delivery and
best achievable follow-up program. However, the regulations are falling behind the fast
developments in imaging and dose delivery technologies due to various reasons. Research
communities are working intensively to develop QA tools and methods to accommodate
with new advanced equipments and techniques. The need for more comprehensive QA
programs for the new techniques has been presented in several articles [18] [60] [61]. In
this thesis, the interest revolves around the pre-treatment QA part of the whole radiation
therapy chain.
The International Atomic Energy Agency (IAEA) and International Commission on
Radiological Protection (ICRP) conducted several studies on the mis-administration of
radiation dose and the causes of the inadequacy of the existent QA programs within the
clinics of the study [62] [63] [64] [65]. In brief, the causes includes 1) Incorrect data trans-
fer from the imaging system to the TPS, then to the record and verify system (or oncol-
ogy information system) and finally to the linac. 2) Incorrect IMRT or VMAT treatment
planning especially in the early days of emerging techniques where the dose calculation
accuracy was an issue of concern. Moreover, inexperienced handling of new software and
delivery techniques could lead to inaccurate optimization process. 3) Mis-calibration of
the dose delivery unit. Traditional calibration procedures are not incorporating aspects
relevant to advanced dose delivery techniques (finite sizes of the leaves, dynamic MLC,
rotating gantry). 4) Inappropriate usage of the dosimeters. Dosimeters are calibrated to
specific radiation conditions. The calibration is affected by changes in environmental
conditions (such as temperature, pressure ...). Moreover, depending on the goal of the
measurement, the choice of the appropriate dosimeter is required. The wrong choice can
compromise the accuracy of the measurement.
For those reasons mentioned above, medical physics communities agree on the need for
additional components in QA programs [18]. For instance, independent dose calculation
engine and dose delivery verification have to be implemented for each patient. The new
components have to be compatible with clinical time frame and not add (if not decrease)
workload to the personnel. To this end, several approaches have been introduced and
translated into certified apparatus and software packages specifically designed for the
pre-treatment QA.
Most of the treatment planning systems can create a verification plan that suits the
adopted dosimeter and phantom. A region of interest within the phantom that matches
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the dosimeter is defined. The dose calculated in the verification plan within the region of
interest of the phantom is compared against the measurement performed by the dosime-
ter. Historically, the pre-treatment QA was performed using single point measurements
utilizing ion chambers or TLDs. As an advancement, radiochromic films and 2D arrays
of ion chambers or diodes have been introduced within tissue-equivalent or anthropomor-
phic phantoms. Recently, commercial devices embedding a detector configuration for 3D
volumetric dosimetry have also been adopted. Though, these devices rely on interpola-
tion and extrapolation algorithms from several 2D projections (not just measurement) to
provide a 3D dose distribution. The only dosimeters that actually measure full 3D dose
distributions are polymer gel dosimeters and radiochromic 3D detectors [18]. Though,
these types of detectors are not widely used to their passive and single use nature.
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Electronic Portal Imaging Device design
and clinical usage
3.1 Background
In radiation therapy, daily checks for accurate treatment setup are crucial. Despite the
advances in technology, verification of the dose delivery to the tumour as planned remains
practically difficult. The difficulties manifest in several factors which vary daily. Namely,
tumor shape, size and location changes over the treatment course which could last for
weeks. Moreover, patient positioning on the treatment couch adds uncertainty factors.
Hence, a methodology to ensure the intended tumor (and organs at risk) position prior to
treatment is required. For decades, film cassettes were used to acquire images from the
linac beam or an external X-ray source for landmark localization purposes. The images
produced by films are satisfying for the intended purpose but have disadvantages. During
the time required for film development, misalignment between the imaging phase and
delivery phase can occur. Additionally, imaging using cassette films is labor intensive
and extend the treatment time. These weaknesses motivate the development of electronic
portal imaging devices (EPID).
In the 1980s, the usage of a fluoroscopic system to acquire megavoltage transmission
images was introduced [66]. The proposed EPID was designed as a large flat screen flu-
oroscopic system. A decade later, manufacturers introduced camera-based fluoroscopic
EPIDs. This approach was refined and developed by several research groups leading to
the introduction of the commercialized camera-based fluoroscopic EPIDs 3.1. During the
1990s, this type of EPIDs was widely used as positioning imaging device in clinics. How-
ever, camera-based EPID has several drawbacks. In particular, the low light output of the
fluorescence screen in combination with the poor light conversion due to the lens aperture
yields a low Detective Quantum Efficiency (DQE) of below 1%, while large lens aperture
would lead to poor resolution due to spherical aberrations [19]. To enhance the DQE,
ionization chamber were explored as an alternative detector but filled with a liquid of
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much higher density than air. The commercial version of the liquid based EPID consisted
of a matrix of 256 ×256 ionization chambers filled with an organic liquid (isooctane)
over an area of 32 × 32 cm2 [67]. In parallel, medical physicists investigate thin-film
photodiodes and transistors for use in photoelectronic imaging devices [68]. The tech-
nology subsequently developed into a flat-panel amorphous silicon (a-Si) imaging array
system (see 3.2). Since the beginning of of 21th century, most of the EPIDs used in clinics
are based on this technology [68]. A comprehensive review of EPID clinical practice is
outlined in [69] [70] [71] [72].
Figure 3.1: Schematic illustration of camera-based EPID [72].
Currently, imaging using EPIDs has applications including the assessment of patient setup
before and during treatment delivery and the advanced assessment of patient motion for
image guided radiation therapy (IGRT) [73]. Depending on the X-ray beam, different
imaging is enabled by EPID. The use of the therapeutic beam enables the acquisition of
planar or (by gantry rotation) tomographic MV images. MV images acquired by EPIDs
have poor contrast in comparison to kV images due to low DQE of these detectors at
the high energies where Compton interactions are dominant. Novel structure designs and
image processing methods have been proposed to enhance the DQE and spatial resolution
[74] [75]. When EPID is integrated in the linac gantry, also X-ray kV images can be
acquired and a cone beam computed tomography (CBCT) can be reconstructed [76].
3.1.1 EPID structure and response to ionizing radiation
As stated before, several EPID designs have been introduced and commercially produced
by different vendors. In this thesis, focus is given to the structure and specification of the
EPID installed at the University Clinic. In this clinic, the ELEKTA synergy (ELEKTA
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Figure 3.2: Conceptual drawing of a flat-panel imager proposed by [68].
Oncology Systems, Crawley, UK) linac is equipped with the PerkinElmer XRD 1640 AL5
P a-Si EPID (ELEKTA iViewGT).
Modern EPIDs are based on indirect photon to signal conversion, relying on electron
to photon conversion mechanism (scintillation). The EPID exploits the so called active
matrix flat panel imager (AMFPI) technology [77]. The imager consists of a pixelated
photodiode array based on hydrogen-doped amorphous silicon (a-Si: H) semiconductors.
Each photodiode is connected to a thin film transistor (TFT) to switch the readout signal,
and both are mounted on a glass substrate. A scintillator made of terbium doped gadolin-
ium (Gd2O2S:Tb) or cesium iodide (CsI) is sandwiched between the array and a 1 mm
thick copper build-up plate. The imager is encapsulated in a low-density plastic cover
and laterally connected to a readout electronics. Figure 3.3 schematically illustrates the
structure of the EPID.
Figure 3.3: (a) Schematic structure of EPID and the indirect conversion of ionizing radiation
through scintillation. (b) An example of an a-Si 3× 4 pixel array and associated electronics [19].
When the incident ionizing photon beam strikes the imager, the low energy scattered ra-
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Table 3.1: Comparison of two state-of-the-art EPIDs.
EPID model PerkinElmerXRD 1640
VARIAN
a-Si1200
Scintillator screen CsI Gd2O2S:Tb
Pixel number 1024×1024 1280×1280
Active area (cm2) 41×41 40×40
Pixel size (mm) 0.40 0.39
Maximum frame rate
(fps) 3.5 25
diation is attenuated by the build-up plate while the high energy photons are converted
into secondary electrons. The converted electrons (and the unconverted photons) inter-
act with the scintillation layer producing a shower (glare) of optical photons which is
efficiently absorbed by the photodiode array generating an electric charge. The charge
is integrated into the capacitive element of each pixel and controlled by the TFT switch
which manages the bias between the photodiodes and the signal line 3.3(a). The un-
converted incident photons may be directly detected by the photodiodes, however, the
indirect detection has a gain which is one order of magnitude larger [78]. EPIDs using
a-Si technology shows a conversion efficiency superior to other technologies, considering
that about 50% of the light emitted from the scintillator is converted into a charge signal
[72]. Furthermore, solid state technology gives the advantages of almost real-time, digital
and pixelated readout with relatively large detection area. Thus, all the modern linacs are
combined with a-Si EPID to enable IGRT applications.
Commercially, a-Si EPIDs are manufactured by PerkinElmer R© to be integrated into
ELEKTA and Siemens R© linacs and VARIAN R© to be mounted on VARIAN’s linacs.
Both manufacturers share the same conceptual design [77], though, they vary in technical
specifications. The state-of-the-art EPID specifications for the two vendors are given in
table 3.1.
3.1.2 Imager readout and acquisition system
The a-Si EPID structure is the same for both manufacturers but electronics and signal
readout systems can vary in approach. In this work, PerkinElmer EPID is used and hence,
signal readout and image acquisition is presented in depth.
The EPID panel is split electronically into two halves. Each half has eight separate read-
out regions (ROG). Each ROG is read row by row from the edges to the center, thus in
opposite direction for the two halves. Figure 3.4(a) illustrates the electronic separation on
a schematic layout of the panel and ROGs while figure 3.4(b) depicts the readout separa-
tion effect in an offset image (with no radiation applied).
Using a relatively complex reading layout introduces many advantages. For instance, the
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Figure 3.4: (a) Schematic layout of a PerkinElmer EPID with two isolated halves, 8 ROGs per
half [79]. (b) Offset image acquired with a PerkinElmer EPID.
reading pattern enables to minimize the bias in signal collection of a large sensitive area,
leading to optimized collection time and negligible dead time. Because of the capacitive
feature of each pixel, the signal is stored till reading and, subsequently, annealing. After
reading completion, the pixel signals are transferred as a single frame to a frame grabber
equipped computer. Typically, the frame acquisition time for PerkinElmer EPID is be-
tween 0.43 to 0.14 sec. In principle, the frame acquisition time includes the integration
time (depending on acquisition setting) and the reading time (depending on electronics). It
is worth emphasizing that during signal integration, the pixels keep collecting the signals
till the end of acquisition or saturation. This feature is crucial in low dose measurements,
which are relevant for this thesis. Figure 3.5 illustrates the readout scheme for each frame.
Image acquisition, in general, follows two modes. Firstly, in integrated mode all image
frames are summed to produce a single image. This imaging mode works well for lo-
calization purposes but not for tumour tracking, IGRT or dosimetric purposes. Secondly,
in cine “or movie” mode image frames are continuously transferred to the computer at a
fixed rate. Both major linac vendors (ELEKTA and VARIAN) provide the user with the
two modes. Yet, the acquisition options (e.g. spatial resolution, frame rate, image type
and extension ...) vary with a dependence on vendor, linac type and operating software
(and version).
3.1.3 EPID for dosimetric purposes
EPID has been proved to be a useful tool for landmark localization prior to and dur-
ing the treatment. Yet, geometrical accuracy does not guarantee the dose delivery to
be as planned. To this purpose, several researchers have been proposing the possibil-
ity to extract dosimetric information from the EPID images. The fact that EPID has an
approximatively linear response to radiation, digital and real-time readout, high spatial
resolution and rigid attachment to the linac motivates the researchers to investigate and
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Figure 3.5: Readout pattern of a Perkin Elmer EPID. Regions A, B, and C are the integrated
signals from frame 1, 2, and 3, respectively [79]
develop such detector type to fulfill the dosimetric requirements. Before the a-Si EPID
introduction, the dosimetric properties of the liquid-filled ionization chamber EPID have
been clinically investigated [80] [81]. On the other hand, also the camera-based EPID
dosimetry has been studied and developed by several groups [82] [83] [84]. Both EPID-
based dosimetry systems showed interesting characteristics and superior advantages over
other dosimetric devices back then [67]. Nonetheless, a-Si EPID has paved the way for
a new era of EPID-based dosimetry, and almost all modern linacs are equipped with this
type of EPID.
3.1.3.1 EPID dosimetric properties and challenges
There is a considerable variety of EPID dosimetric characterization tests in the literature.
Although the typical layout of the a-Si is similar for both vendors (i.e. PerkinElmer and
VARIAN), technical details like pixel size, array size, image acquisition mode implemen-
tation and the physical housing of the EPID make every model somehow unique [18]
[85] [86]. Here, the focus will be on the major challenges of PerkinElmer EPID-based
dosimetry.
1. Pixel response linearity with dose: In principle, the pixel should respond linearly
with radiation intensity. In practice this is approximately true but some deviations
may occur. These deviations could be due to photodiode saturation, pixel defect,
incomplete signal acquisition, ghosting effect or dose rate dependency. The level of
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deviation varies with EPID model and acquisition software version. Thus, absolute
dose calibration of pixels has to be EPID specific. The literature extensively in-
vestigates different EPID types, and several corrections are proposed [79] [87] [88]
[89] [90].
2. Energy dependent response: EPID exhibits higher response to low energy pho-
tons (< 0.5 MeV) as compared to a water equivalent detector due to the increased
occurrence of the photoelectric interaction in the copper plate and the scintillation
layer (figure 3.6) [91].
Figure 3.6: Energy sensitivity of an a-Si EPID, normalized at 10 MeV, compared to a water
equivalent detector [92].
Over-response could reach 20% difference with respect to ionization chambers, es-
pecially in low dose areas (e.g. inter-leaf transmitted radiation). Scatter radiation
from the MLC and other linac head components increases the low energy radi-
ation component of the beam. In addition, the EPID component itself adds un-
wanted scatter to signal. This impacts the readout in the off-axis region and the
dose response of different field sizes (regular and irregular filed shapes). Several
approaches have been proposed to model the low energy components using simula-
tion or empirical methods [79] [92] [93]. However, modelling becomes harder for
the VMAT technique where continuous modulation of the beam shape is applied.
3. Pixel sensitivity variation: Each pixel in the a-Si array has a specific offset signal
and a specific gain response to radiation. The signal variation is due to the intrinsic
response difference between pixels in combination with differences in the readout
system [94]. In general, the difference in pixel specific offset and gain response
can be corrected by irradiating the entire array to a uniform mono-energetic beam.
However, this is not achievable in practice because the linac generates a spectrum of
energies with non-uniform intensity distribution. Nevertheless, the non-uniformity
of the beam is negligible for imaging purposes and, hence, manufacturers use a
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flood-field, that is an open field covering all sensitive area of the EPID, to create
a Pixel Sensitivity Map (PSM) and then normalize each pixel response. In con-
trast, non-uniformity has a significant impact on calibration of the pixel response
for dosimetric purposes, especially when the EPID is moved away from the central
axis. Two methods have been proposed to create beam independent PSM. In ref-
erence [95], authors suggest that using a 10 cm water equivalent build-up medium
(above the EPID) could improve the uniformity of the beam intensity. On the other
hand, to ensure a uniform intensity irradiation, authors of reference [87] propose a
method to irradiate all pixels by a fixed small field at the center. The latter method
proved to be more useful for dosimetric calibration.
4. Optical glare: The scintillation layer of the EPID converts the incident secondary
electron into optical photons to be detected by the photodiodes. A secondary elec-
tron yields a shower of optical photons diffused downward resulting in a blurring
effect (figure 3.7). The blurring could quantitatively affect the dose, and similar to
imaging, should be accurately characterized to compensate for partial volume ef-
fect. However, this effect on modern EPIDs is limited thanks to the relatively small
thickness of the scintillation layer and the short distance to the photodiode. Though,
a simple kernel representing the point spread function of the system response is pro-
posed to enhance image sharpness and consequently dose distributions [96].
Figure 3.7: (a) An X-ray incident from the left undergoes Compton scattering in the reflective
support layer. (b) The Compton electron proceeds and deposits energy within the scintillation
(phosphor) layer, thereby generating optical photons. Some optical photons are then absorbed by
the photodiode, after scattering throughout the scintillation layer [97].
In the past two decades, researchers have investigated and proposed numerous methods
for EPID dosimetry serving several purposes. Extensive reviews about EPID dosimetry
have been carried out, covering the period 1991-2008 [67] and till mid 2016 [18]. In
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this thesis, the historical development of currently used techniques and methods, cover-
ing publications till mid 2018 is presented.
There are more than 100 publications on EPID dosimetry ranging from the investiga-
tion of detector properties, problem-solving and developing of new methodologies. In
general, the developed methods are either to conduct transit dosimetry or non-transit
dosimetry. Transit dosimetry is referred to a dosimetry of a beam passing through media
(either patient or phantom) while non-transit dosimetry referred to a dosimetry of unat-
tenuated beam or in–air dosimetry. Though, another categorization could be done based
on the dosimetry purposes. Namely, pre-treatment or during treatment (in-vivo) verifica-
tion dosimetry. Since the thesis is developing pre-treatment verification dosimetry, EPID
dosimetry review is categorized accordingly. However, in addition to pre- and during-
treatment categorization, each category is sub-categorized in dosimetric dimensionality
(i.e. 1D, 2D, 3D or 4D).
3.1.4 Dosimetry for pre-treatment QA
In order to develop a pre-treatment QA dosimetric tool based on EPID technology, the
main task is to develop a methodology that enables to compare the dose delivered by the
linac with the planned dose distribution. Serving this principle, two main approaches are
used to conduct EPID-based dosimetry for pre-treatment QA.
3.1.4.1 2D Dosimetry
• Predicting the EPID image: Using the dose calculation engine of the TPS or inde-
pendent engines, the expected 2D EPID image obtained by delivering each beam of
a treatment plan is predicted. For non-transit dosimetry, this approach has to incor-
porate two models for prediction. One to account for the energy fluence from the
linac head component (including MLC positions) and the other to account for the
EPID response (including detective quantum efficiency, dose to signal conversion,
attenuation per layer). Predicting 2D images is widely used in clinics nowadays.
VARIAN distributes a commercial software (Portal Dosimetry R©, Varian Medical
Systems, Palo Alto, CA) and numerous investigations have been conducted on dif-
ferent versions of this software [98] [99] [100] [101] [102] [103] or on developed
versions of the algorithm [104] [105]. Other groups have independently developed
algorithms that predict the 2D image at the EPID level using a dose calculation en-
gine different from the TPS [106] [107] [108] [109] [110]. However, this approach
may be designated as 2D verification method rather than a dosimetric method since
the EPID image is not a representative of dose in water and cannot be used as a
clinical dosimeter.
• Converting the EPID image into dose in water: In order to enable the measurement
verification, few groups have developed algorithms to convert 2D EPID images to
2D dose distributions [79] [111] [112]. Other groups have proposed changing the
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EPID structure. For example, increasing the build-up plate thicknesses, removing
the scintillation layer or adding backscatter shielding. Based on the 2D dose dis-
tribution at EPID level, some researchers have proposed methods to reconstruct
(back-project) the 2D dose distribution as imparted into a virtual water cubic phan-
tom at patient level [111] [113] [114].
3.1.4.2 3D dosimetry
Two approaches have been proposed to reconstruct a 3D dose distribution in a phantom or
patient. In the first method, the EPID image is converted to energy fluence and then back-
projected upstream to the linac head level. The back-projected fluence is then inserted
to a dose calculation engine to generate the dose within the phantom/patient [115] [116]
[117]. The second method has been recently proposed and is based on directly converting
the EPID image to 2D dose distribution and then back-project it to a virtual water phantom
[118] [119].
3.1.5 In vivo dosimetry
Proposed methods for in-vivo dosimetry are essentially utilized for patient transit dosime-
try.
3.1.5.1 1D dosimetry or point dosimetry
As a first step, researchers have worked on finding a correlation between the signal mea-
sured by the EPID and the dose along the central beam axis using back-projection algo-
rithms [120] [121]. The approach has gained success due to its simplicity and has been
validated for different treatment plans [122] [123]. Several groups have investigated and
developed point dose verification even for complex radiation delivery techniques [124]
[125]. This approach is also commercially available as SOFTDISO (Best Medical, Italy)
and EPIgray (DOSIsoft, Cachan, France).
3.1.5.2 2D dosimetry
As an extension of the point dose verification, authors of reference [126] developed a
method to reconstruct a 2D dose distribution at the iso-center level using semi-empirical
conversion factors extracted from a measured 2D dose distribution in a water equivalent
phantom. A similar approach but using patient radiological thickness (acquired from pa-
tient CT) to account for attenuation has been initially proposed in [127] and developed
in [128] [129]. Authors of reference [130] have also quantitatively investigated this ap-
proach. Another method for 2D verification has been implemented by predicting the dose,
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energy fluence or even the image at the EPID level with the presence of the patient. In
principle, this approach requires EPID calibration to convert the 2D image into 2D dose
distribution or 2D energy fluence or, in case the image at the EPID level is predicted, an
exhaustive prediction modeling of the dose delivery and imaging systems. For all cases,
the prediction can either use a MC or analytical dose calculation engine [131] [132] [133].
3.1.5.3 3D dosimetry
Instead of predicting the 2D dose distribution at the EPID or iso-center levels, the EPID
image is converted to dose or energy fluence, back-projected upstream above the patient
entrance point and then inserted into a dose calculation engine to generate the 3D dose
distribution relying on patient CT. With minor technical differences, this approach has
been proposed by groups [115] [134] and the works are mostly focused on developing
the dose calculation to incorporate the variables relevant to VMAT treatment plans [135]
[136] [137] [138] [139] [140]. ELEKTA adopted this approach and distributes the system
as Iview-Dose software to be exclusively implemented in ELEKTA linacs.
3.1.5.4 4D dosimetry
Recently, the inclusion of the time variable in in-vivo dosimetry has been proposed. The
effective clinical need of such approach is argued in [141] [142]. Authors of reference [79]
proposed a time-dependent method for EPID dosimetry. This method has been initially
proposed for pre-treatment QA and is now under development for 2D time resolved in-
vivo dosimetry. A simulation has been recently published proving the feasibility of time-
resolved dosimetry [143].
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Chapter 4
Dosimetric characterization of the
EPID
4.1 Introduction and motivation
The advantages of EPID performing dosimetry were widely presented in the previous
chapter. Though, prior to being clinically useful, EPID requires a calibration process
supported by several measurements. Literature has proposed numerous methods for cali-
bration. Each method has advantages and disadvantages depending on its specific perfor-
mance and applicability. The results of these methods vary considerably within different
EPID technologies and generally are not even consistent for the same EPID model [90].
When comparing different EPID models, the dosimetric characteristics are influenced also
by the acquisition systems [144]. Consequently, there is no a method that can be gener-
ally applied to all EPID models. For this reason, a comprehensive characterization of the
EPID, including the readout system and the image acquisition modes are required before
the establishment of a calibration method. In this chapter, the EPID used throughout this
work is characterized in terms of the signal profile, offset signal, image lag, linearity with
dose and dose rate, response to different energy spectrum and variation of pixel sensitivity.
4.2 Materials
4.2.1 Linear accelerator and EPID
All measurements were performed on ELEKTA synergy (ELEKTA Oncology Systems,
Crawley, UK) linac using 6 MV photon beams. The linac is equipped with Elekta
Agility collimator, consisting of 80 leaf pairs and two perpendicular diaphragms and two
PerkinElmer XRD 1640 a-Si EPIDs (ELEKTA iViewGTTM and XVI). The two EPIDs
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share the same physical structure and electronics except for the additional build-up layer
on top of the MV EPID. The XVI EPID is used for kV imaging and is mounted perpen-
dicularly to the X-ray source for the treatment. The iViewGT EPID is the most widely
used detector for MV imaging and, unless stated otherwise, it will be addressed as the
EPID from now on. The EPID is mounted at a source-surface distance (SSD) of 160 cm
(z direction) having the freedom to move in cross-line (x) and in-line (y) directions. The
EPID has a sensitive area of 41 × 41 cm2 corresponding to a field size of 26 × 26 cm2
at the iso-center plane. Detailed technical specifications of the used EPID is outlined in
table (3.1). The structure of linac and EPID is typically designed as presented in chapter
2.3. Figure 4.1 shows the outer appearance of the Linac head and the EPID.
(a) (b)
(c)
(1)
(2)
(3)
(4)(5)
Figure 4.1: (a) ELEKTA linac components: (1) beam source, (2) linac head (includes MLC and
jaws), (3) EPID, (4) X-ray source, (5) kV EPID. (b) A picture of the MLC defining the field shapes.
(c) The EPID, without the plastic cover.
4.2.2 Image acquisition and software
Originally, ELEKTA has separate Personal Computers (PC) and software for linac, pa-
tient data, EPID and kV imaging system. The EPID is connected to the PC (labeled
54
4.3. METHOD
iViewGTTM as the EPID) via a frame grabber module through an independent digital ca-
ble. The frame acquisition is managed using the X-ray imaging software (XIS) provided
by Perkin Elmer. The XIS captures 16-bit raw (uncorrected) images in Heinemann imag-
ing (HIS) format. The software includes the different image corrections and adjustment
tools. The software offers three acquisition modes: the single acquisition mode, the dou-
ble or multiple-exposure mode and the movie-exposure mode. For each mode, a frame
averaging parameter can be set before the acquisition. However, the number of acquired
images is limited to 256 image frames and there is no possibility to enable free raw im-
age acquisition. To overcome this limitation, a stand-alone PC was used to acquire the
raw images directly generated by the EPID. The PC was equipped with a frame grabber
and and a c++ code (named: iCom-logger) developed at the LMU by Dr. M. Podesta
in the framework of the European Society for Radiotherapy and Oncology Technology
transfer grant from Maastricht University. ICom-logger is designed to capture the im-
age frames in a free-running mode with a resolution of 1024×1024 pixels and pixel size
of 0.4×0.4 mm2. These image frames were labeled with their acquisition time in time
Unix timestamp format with a temporal resolution of hundreds of millisecond. The im-
age frames storage was triggered and stopped manually at the beginning and the end of
the measurement and had a frame rate of 2.3 frame per second (fps). In parallel, ELEKTA
system includes a package named iCom-Vx which provides an interface between the PC
iViewGTTM and the linac control system. The iCom-Vx functions include the automatic
selection and creation of patient data and the automated acquisition of images on the PC
iViewGTTM. An in-house code was developed to mimic the generation of the linac con-
trol system trajectory file (namely, the linac log file). The developed code extracts also
the linac output files labeled with time Unix timestamp format in nanosecond resolution.
The linac trajectory file registers instead four messages per second.
All image processing conducted in this chapter were carried out using MATLAB (Math-
works Inc., Natick, MA) on an off-line PC.
4.3 Method
The features that are adopted to characterize the EPID are structured according to the
following sequence:
1. EPID signal profile As described earlier, the EPID collects the signals from the
16 readout regions of the sensitive area according to a specific pattern to produce
the image frame. The annealing of the photodiodes after integrating the signal
generates a dead time which influences the image frame especially at the beginning
and the end of the beam delivery. The general characteristics of the EPID signal
profile are assessed during irradiation (beam-on) using the default maximum dose
rate (i.e. 530 MU/min).
2. Offset correction Each pixel detects a persistent signal so that the pixel value (PV)
is always above zero even when no radiation is incident (beam-off). The raw im-
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age acquired during beam-off is called offset (also referred to as dark current or
dark field) image. The pixel values of the offset image are subtracted from each
consecutive image frame allowing response values to start from zero.
3. Image lag (ghosting effect) The image lag (also referred to as ghosting effect) char-
acterizes the image frame with the presence of signal from the previous frame(s).
This effect influences the absorbed dose by adding spurious signal to the image
frame(s) during irradiation (beam-on) or after (beam-off). The effect of the image
lag on the EPID signal fall off during beam-off is quantified for doses varying from
2 MUs to 1000 MUs.
4. Dose response linearity Linearity of the EPID signal with respect to the absorbed
dose is the essential feature required for any detector to be used as a dosimeter. In
order to assess the linear response of the EPID, the average signal of a 9 by 9 pixel
matrix centered in the image frame is calculated for irradiations with 5, 10, 20, 50,
100, 300 and 500 MUs. To assess the dose response linearity, the cumulative sum of
these average signals is reported as a function of dose. The considered acquisition
starts 10 frames before beam-on and ends 10 frames after beam-off.
5. Dose rate dependence In conventional treatment techniques, the dose rate is con-
stant during beam delivery. In contrast, VMAT is distinguished by the continuous
modulation of the dose rate. Hence, the linac is set to deliver a dose corresponds
to 50 MU by applying 100, 150, 300, 500 as maximum dose rates (MU/min). The
EPID signal is measured for the different dose rates and the deviation with respect
to the integrated EPID signals is calculated to quantify the dose rate dependence.
6. Pixel sensitivity The individuality of the offset signal exhibited by each pixel on the
image frame is manifested also in gain caused by pixel specific response or different
efficiency of the readout system. To obtain an estimation of the pixel sensitivity,
the EPID is irradiated with a uniform flood-field covering the entire sensitive area
(i.e. 26×26 cm2). Image frames acquired during stable irradiation are averaged
and subtracted to the offset image, thus resulting in the pixel sensitivity map. The
obtained map is normalized and used to correct for pixel sensitivity the image frame
and produce a uniform image.
7. Field size effect (output factor) Field aperture has a significant impact on the
beam spectrum and energy distribution (figure 2.15). As stated before, the energy
dependent response is one of the main difference between the a-Si EPID and the
water equivalent dosimeter. To characterize the field size effect, the average of the
EPID signal within a central 3 by 3 pixel matrix is determined for irradiation with
different field sizes of 3×3, 5×5, 10×10, 15×15 and 26×26 cm2. For comparison,
corresponding reference measurements are performed using the Farmer ionization
chamber (IC) in a water equivalent phantom (RW3 slab phantom). The IC is placed
at the center of the field at a distance of 160 cm from the source and 3 cm depth in
a 30×30×30 cm3 phantom.
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4.4 Results
1. EPID signal profile
The pixel values at the center of the raw image of the EPID irradiated with 10,
50 and 100 MUs are plotted in figure 4.2. The signal profile over time for each
dose may be categorized into three regions. (a) The first region starts with non-dose
related signal (offset signal) that increases as the EPID is irradiated. This region can
be modeled depending on the linac ramp up and the EPID reading pattern. (b) The
second region is where the response is expected to be constant, however, it shows a
slight fluctuation and gradual increase in gain. (c) The fall off region represents the
signals after the beam-off. The signal decreases according to an exponential decay
indicating the ghosting effect of the detector (see 3).
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Figure 4.2: The EPID central signal profiles without corrections for 10, 50, and 100 MUs at a
dose rate of 530 MU/min. The three regions characterizing the EPID signal profile (a)(b) and (c)
are zoomed.
Figure 4.3 illustrates the image frame reading of a 10×10 cm2 field from the begin-
ning of irradiation till the end. The reading pattern appears to start from the EPID
center propagating outward. After few image frames, the EPID shows a uniform
reading. After the beam-off, the EPID detects the preserved signal from its center
outward to the edges.
2. Offset correction Several offset images are acquired after 20 frames, minutes and
hours after irradiation. Image ghosting effect (see 3) is found to affect the irradiated
regions after the beam-off for minutes, especially with high doses. Though, signals
return to the initial state eventually. Figure 4.4 shows an example of an offset image.
3. Image lag (ghosting effect)
In figure 4.5, the pixel value at the center of the image frame recorded by the EPID
as a function of time is compared to the delivered dose rate, as obtained from the
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Figure 4.3: Measured image frames indicating EPID reading pattern.
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Figure 4.4: (a) Scatter plot of the offset signal. (b) offset (dark field) image.
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linac trajectory file. The figure eases the discrimination between direct and indirect
effects of the irradiation on the EPID signal. The signal starts a few milliseconds
after irradiation and rises up as dose increases. However, the signal keeps increasing
slightly even when the dose rate reaches stability. When the beam is off, the signal
still gives positive readings indicating the ghosting effect. For quantification, the
fall off for different dose rates is illustrated in figure 4.6. For 500 MU, the EPID
requires 10 frames to reach 1% difference with respect to the offset in pixel value.
Figure 4.5: EPID signal at the centre of the panel for a 50 MU delivery and the linac output in
terms of dose rate. Both plots are in function of time.
4. Dose response linearity
Based on the EPID signal acquisition with different dose rates, the cumulative cen-
tral signals are reported against doses in figure 4.7(a). A first-degree polynomial
fitting function is applied resulting in coefficient of determination R2 = 1. The
parameters of the function are expressed in the formula:
Dose(MU) = 0.16× 10−3(IntegratedSignal(PV )) + 0.33 (4.1)
Figure 4.7(b) is similar to figure 4.7(a) but the ordinate axis is scaled logarithmically
to illustrate the validity of the fitting even for low MUs.
5. Dose rate dependence Since the dose rate during delivery differs from the one of
the user settings, the real dose rate is retrieved from the linac log file as a function
of time. In figure 4.8, the central EPID signals are reported for each dose rate.
Notably, since the EPID signal starts increasing milliseconds before irradiation,
either the recorded time for the dose rate delivery or the EPID frame acquisition
time are affected by a time offset. In figure 4.9, the integrated signals acquired for
the different nominal dose rates are normalized to the central value and displayed
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Figure 4.6: Central EPID signal after beam-off for different MUs (a) Linear ordinate axis scale.
(b) Logarithmic ordinate axis scale.
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Figure 4.7: Cumulative central signals for different MUs and the applied linear fitting. The ordi-
nate axis is scaled (a) linearly and (b) logarithmically.
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against the average real dose rate recorded in the linac log file. The maximum
deviation between the integrated signals obtained by the maximum and lowest dose
rate is found to be ≈ 3%.
6. Pixel sensitivity Figure 4.10(a) shows the energy distribution of a flood-field as
calculated by the TPS while figure 4.10(b) shows the EPID signal in response to the
same flood-field. Normalized cross-line and in-line profiles of both distributions are
plotted in figure 4.11.
7. Field size effect (output factor) Central doses acquired by the ionization chamber
(IC) and integrated central EPID signals are plotted as a function of different field
sizes. In both figure, the values are normalized to the value of the 10×10 cm2 field.
4.5 Outlook
The EPID signal in response to radiation shows the desired features for dosimetry. The
EPID provides a real-time image acquisition synchronized with the linac beam delivery.
For frame by frame dose representation, however, EPID suffers from ghosting effects
which influence the linearity of the overall dose, as already presented in literature [88]
[89] [122]. Surprisingly, EPID showed excellent linearity for integrating dose-response
comparison even with low doses suggesting two possible explanations. Either the signals
recorded after irradiation are dose-related and emerged as a result of signal storing and
reading mechanism of the system, and hence, elimination of these signals affect the lin-
earity. Alternatively, the lag is proportional with overall dose elimination of these signals
have no direct impact on the integrated dosimetry. Either way, authors of reference [90]
suggested that non-linearity can be explained by the lack of image acquisition and read-
out system characterization. Nevertheless, the excellent linearity of the ELEKTA’s EPID
implies that all signals are adequately preserved. The image acquisition software pro-
vided by the manufacturer starts the frame acquisition a few milliseconds after beam-on
and stops a few milliseconds after beam-off. This results in missing information which
demonstrates to be valuable for dosimetric usage of the EPID. Hence, a software enabling
the free running image acquisition is needed to account for the offset image (directly
before the irradiation) till the fall off. Dose rate shows to have an impact on the inte-
grated EPID signal when compared to the total delivered dose. The difference can be
due to the unstable linac output especially for low dose rate. The EPID signal, how-
ever, demonstrates a direct correlation with pulses generated by the linac for the different
dose rates which gives room for adequate accounting of dose rate dependence. The EPID
exhibits non-uniform pixel sensitivity to radiation. Furthermore, the flood-field shows
non-uniformity in dose distribution in comparison to the flood-field energy fluence. The
signal increases when propagating radially away from the center. Though, the radial dis-
tribution is not fully symmetric as the cross-line profile next to the EPID electronics shows
over-response than the others. Comparing the fluence and EPID profiles of the flood-field
demonstrates the effect of EPID inner scatter radiation and the over response to the off-
axis radiation. This effect requires robust correction for pixel sensitivity, as a function of
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Figure 4.8: Different nominal dose rate sets and the real dose rate recorded by the linac log files
in conjunction with the central pixel values acquired by EPID for the correspondent time.
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Figure 4.9: Normalized values to the center of the integrated central pixel values as a function
of the average recorded dose rates for different nominal dose rates (100, 150, 300, 500, 600 and
maximum dose rates (MU/min)).
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Figure 4.10: (a) Energy distribution calculated by the TPS. (b) Pixel sensitivity as detected by the
EPID image.
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Figure 4.11: EPID profiles and fluence in cross-line and in-line directions.
Figure 4.12: Normalized central pixel values measured by the ionization chamber and integrated
by the EPID for a fluence of 100 MUs and different field sizes. Both images were normalized to
their central value.
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the energy fluence. On the other hand, the difference in response between the EPID and
the water equivalent dosimeter appears evident when comparing for different field sizes.
The over-response (for large fields) and low-response (for small fields) demonstrate the
well known energy dependency of the EPID. In conclusion, the EPID has good potential
to perform as a dosimetric device. However, several image corrections and calibration
methods have to be applied to satisfy the dosimetry requirements for clinical usage.
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Chapter 5
EPID calibration to dose in water
In general, two approaches have been proposed in the literature to calibrate EPID for
2D dosimetry. The first approach is based on the conversion of the 2D gray scale im-
age as acquired by EPID to absorbed dose in water while the other relies on simulation
(or prediction) of the 2D gray scale image. For both approaches, several methods have
been described to satisfy the dosimetric purposes. In this thesis, the calibration aims at
generating an independent, fast, accurate and simple pre-treatment QA tool for the differ-
ent treatment techniques used in the clinic. Knowing that the prediction of the 2D gray
images becomes challenging for complex treatment techniques and the accuracy of mea-
surement heavily relies on the prediction integrity [79] [145], the other approach relying
on the conversion of the 2D gray scale image to absorbed dose in water has been chosen.
For this purpose, a set of calibration measurements is required. Thus, validation can be
performed using any clinically available reference dosimeter.
In the light of the characteristics observed on the ELEKTA’s EPID in the previews chap-
ter 4, several corrections needed to be applied before calibration. In this chapter, the
initial correction includes offset, dead pixels, and pixel sensitivity followed by calibration
methods is explicitly developed to fulfill the dosimetric goal.
5.1 Material and Method
The linac, EPID and image acquisition system and software used in this section are the
same used in chapter 4. The dosimeters and phantoms used for calibration and validation
are declared upon its usage in the following sections.
5.1.1 Offset correction
Prior to irradiation, 5 EPID image frames were acquired without any irradiation and av-
eraged to obtain virtually noise free pixel values. The pixel values were assumed as an
67
CHAPTER 5. EPID CALIBRATION TO DOSE IN WATER
offset of the EPID and subtracted from each image frame acquired in the following.
5.1.2 Dead pixel correction
Due to irradiation or current fluctuation, some pixels may be damaged or poorly respond-
ing to radiation. Different from the manufacturer correction based on a threshold, the
pixel values were discriminated according to their linear or non-linear response. All the
pixels were irradiated with flood-field of intensity equal to 100 MU, and 20 image frames
within the stable beam were acquired. For each pixel, the sum of 20 image frames was
divided by the sum of the first 10 image frames. The pixels deviating from linearity by
more than 1% were marked as dead pixels. The procedure led to a binary mask. The mask
was then used to correct each image frame in the following by replacing the dead pixel
with the average value of the 8 neighboring pixels.
5.1.3 Pixel sensitivity correction
Although the pixels respond linearly to the intensity of irradiation in general, they can be
characterized by different response rates. This difference can be accounted for in image
processing by using the sensitivity characterization presented by [87] and improved in
[79]. All pixels of the EPID image frame were meant to be irradiated with photon beams
of the same intensity and spectrum. However, the beam intensity and spectrum are not
uniform. Besides, the uniformity is additionally compromised by the scattered beam from
the EPID. Exploiting the movability of the EPID in cross-line and in-line directions, the
EPID at first, was irradiated with a static 10 × 26 cm2 rectangular field, centered to the
EPID to gain maximal uniformity. The image frames were acquired while moving the
EPID along the x-direction in 4 cm step size. Then, a static 26 × 10 cm2 rectangular
field at the center was used, the EPID was moved along the y-direction in 4 cm step size
and the image frames were acquired. The in-line profiles were combined to form the
in-line 1D profile. Figure 5.1 illustrates the acquisition process. The field size and step
size were chosen according to a trade-off between accuracy and efficiency (acquisition
time) of the calibration. With reasonable approximation (deviation less than 0.5%), the
central 2 × 2 cm2 of each square field is relatively uniform. The 2 cm cross-line profile
at the field center was extracted from the cross-line profiles and then combined to form
the 1D cross-line profile. In similar fashion, The 2 cm in-line profile at the field center
was extracted from the in-line profiles and then combined to form the 1D in-line profile.
The obtained 1D cross-line and in-line profiles were then divided by the corresponding
profiles obtained with flood field. The result produced a cross-line and in-line profiles
surrogating the beam inner scattering from the EPID. Assuming that the two surrogate
profiles are radially symmetric, the mean of the two surrogate profiles was taken to reduce
the noise. A 1D Gaussian function was used to fit the mean profile. The fitted function
was then radially interpolated covering the EPID size, thus forming a 2D map of the inner
scattering surrogate. The pixel sensitivity (PS) map was obtained by dividing the flood-
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field image frame with the 2D map of the inner scattering surrogate. Each image frame
in the following was corrected for sensitivity by multiplying the pixel values with the
obtained PS map.
Figure 5.1: A sketch illustrating EPID image acquisition needed for PS correction during (a)
movements along in-line direction and (b) movement along cross-line direction.
5.1.4 Relative off-axis ratio (ROAR)
As the beam inner scattering and the angular response in water differ from those in EPID
media, an Off-Axis to central-axis Ratio for the water equivalent detector (OARw) and for
the EPID (OARe) were defined. Opposite to PS correction, the EPID was fixed, and the
square field moved along cross-line and in-line directions during image frames acquisition
with 4 cm shift (figure 5.2). Similar to PS correction, cross-line and in-line profiles were
combined and averaged. The mean profile was fitted with a second-degree polynomial
function. Radial interpolation of the fitted function on the EPID image frame produced
the 2D OARe. Subsequently, the corresponding reference measurement using a Farmer
ionization chamber (PTW, Freiburg, Germany) (Type No. 30013) was performed in a
water equivalent phantom (RW3 slab phantom), fitted and radially sampled to define the
2D OARw. The division of the OARw by the OARe produced the 2D relative off-axis
ratio (ROAR) map. Each image frame in the following was multiplied by the 2D ROAR
map to correct for water and EPID media difference.
5.1.5 Field size and penumbra correction
The primary photons generated from the beam source are contaminated by the scattering
photons from the multi-leaf collimator (MLC) and other linac components. As the adap-
tation of the field size changes the spectrum of the irradiation, the energy dependence of
the EPID response has to be corrected to match the reference dosimeter. Furthermore, the
correction has to include the scattering from the EPID itself. Hence, the dose, as imparted
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(a) (b)
Figure 5.2: A sketch illustrating fields shift in (a) in-line direction and (b) cross-line direction
with fixed EPID for ROAR correction.
to a water equivalent medium, and the characterization of the EPID response as a function
of different spectra are required. The overall difference between the EPID response and
the reference dosimeter can be modeled by two convolution kernels. For both field size
and penumbra corrections, the choice of the fitting functions was empirically justified by
a negligible fitting error. The first kernel corrects for the filed size dependence and the
second one corrects for the lateral energy deposition and the shape of the penumbra, as de-
tailed in the following. For field size dependence, a radially symmetric kernel was defined
by an exponential fitting function with single decay coefficient. The unknown kernel was
convolved with the integrated EPID image frames irradiated with 100 MU and square field
sides of 3,5,8,10,15 and 26 cm. The central value resulting from the convolution was then
compared with the reference measurement using micro-diamond detector (PTW, Freiburg,
Germany) (Type No. 60019) for the corresponding field size. An iterative optimization
algorithm was implemented to find the best coefficient of the exponential fitting equation
minimizing that difference for each field size. The implementation of the mathematical
optimization is explicitly outlined in appendix (A). The coefficients produced from the
optimization were fitted to cover all possible field sizes with a second-degree polynomial
fitting function. For each EPID image frame, the field area was determined by the number
of irradiated pixels, considering that the energy spectrum depends on the field area of the
MLC, but not on the shape [31]. For penumbra correction, in-line profiles of different
field areas of MLC, as reported in figure 5.3, were measured in a water phantom using the
micro-diamond detector as reference dosimeter and compared to the EPID image frame.
An unknown kernel was defined by a Lorentz fitting function with 4 coefficients for each
field area of the MLC. Unlike the field size correction, a constraint was introduced into
the iterative optimization algorithm to normalize the maximum value of the central in-line
profile. In other words, the optimization had the freedom just to redistribute the penum-
bra fall-off. All the EPID image frames in the following were convolved with the two
obtained kernels.
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(a) (b)
Figure 5.3: (a) and (b) EPID image frames highlighting the fields (#1 and #2) used in penumbra
correction.
5.1.6 Pixel value to dose conversion
Using the micro-diamond detector as reference dosimeter, the absolute conversion factors
from pixel value to dose were obtained. A measurement of the central dose for 10 × 10
cm2 field size was performed for dose values corresponding to the delivery of MUs rang-
ing from 2 up to 1000 MU using a fixed intensity rate of 530 MU/min. The correspondent
doses was delivered to the EPID, acquiring 10 image frames after the beam delivery. The
sum of the image frames was plotted against integrated doses measured by the reference
dosimeter. A linear fitting was used to convert the pixel value to dose of each image
frame.
5.1.7 Validation
For validation, firstly, cross-line profiles of calibrated EPID image frames obtained with
different square field sizes and acquired in air were compared to corresponding reference
measurements using micro-diamond detector in a water phantom. Then, a set of calibrated
EPID image frames of static and step-and-shoot irradiation were validated with respect
to reference measurements based on the diode array detector MapCHECK 2 (Sun nuclear
corporation, Melbourne, USA) (Model No. 1177) with maximum sensitive area of 32 ×
26 cm2. MapCHECK 2 was inserted in a water equivalent phantom (RW3 slab phantom)
at the EPID level (SSD = 160 cm) with 3 cm build-up and 15 cm backscatter.
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5.2 Results
5.2.1 Dead pixel correction
The number of identified defected (dead) pixels is 14 over the total 1048576 pixels of the
EPID image. Figure 5.4 highlights the dead pixels on the EPID image.
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Figure 5.4: The circled dead pixels of the EPID image.
5.2.2 Pixel sensitivity correction
The profiles obtained by moving the EPID in in-line and cross-line directions are plotted
in figure 5.5 along with their correspondent profiles of the flood-field. The second-degree
polynomial function used to fit the profiles is reported in figure 5.6. The correction based
on the senstivity map is depicted in figure 5.7, where the uncorrected and corrected flood-
field EPID images are compared.
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Figure 5.5: Profiles acquired by moving the EPID and the corresponding flood-field profiles for
(a) in-line and (b) cross-line directions.
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Figure 5.6: Combined profile for the in-line direction along with the flood-field profile. The ratio
between the two profiles and its fitting is highlighted.
(a) (b)
Figure 5.7: Pixel sensitivity (a) uncorrected and (b) corrected flood-field image.
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5.2.3 Relative off-axis ratio (ROAR)
Figure 5.8 shows the process of generating ROAR. Figure 5.8(a) illustrates profiles ac-
quired by EPID when moving fields in in-line and cross-line directions, respectively.
Figure 5.8(b) compares between in-line profiles acquired by EPID and micro-diamond
detector. Figure 5.8(c) shows the combined profile of the cross-line profiles. Figure 5.9
shows the resulted ratio between OARw and OARe interpolated radially forming the 2D
ROAR.
5.2.4 Field size and penumbra correction
Figure 5.10 shows the central doses for square field sizes of 32, 52, 102, 152 and 262
cm2 normalized to the 10 × 10 cm2 field acquired by the micro-diamond detector and
EPID and the corresponding field size correction. As visible in figure 5.10, the field size
correction brings the uncorrected EPID images to the reference measurement.
For penumbra correction, the results of the convolution between the generated kernel
and the EPID image is reported in figure 5.11(a). The in-line profile is detailed in fig-
ure 5.11(b) in comparison with the profiles obtained by micro-diamond detector and the
(uncorrected) EPID image.
5.2.5 Pixel value to dose conversion
The relation between the integrated dose measured by micro-diamond detector and the
corrected integrated central EPID pixel values for dose values corresponding to the deliv-
ery of MUs ranges from 2 up to 500 MUs is plotted in figure 5.12. The relation is defined
by a liner fitting function as follows:
Dose(mGy) = (0.00046)× pixelvalue+ (0.75) (5.1)
5.2.6 Validation
The comparison shows visual good agreement between the reference measurements and
the calibrated EPID image frames (figure 5.13). For 2D comparison, the dose distributions
obtained with MapCHECK 2 detector and the calibrated EPID image frames for different
static and dynamic fields are illustrated in figure 5.13. The 2D global gamma evaluation
using (3%, 3 mm) criteria results in above 99% passing rates for all the considered dose
distributions.
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Figure 5.8: (a) In-line and cross-line profiles acquired by EPID for different fields. (b) Com-
parison between in-line profiles acquired by micro-diamond detector and EPID. (c) Example of
combined cross-line profile.
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Figure 5.9: The resulting 2D ROAR.
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Figure 5.10: Central relative doses for different field sizes normalized to the center values mea-
sured by ion chamber and EPID before and after field size correction.
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Figure 5.11: In-line profiles measured by micro-diamond and EPID before and after correction of
(a) field #1 and (b) field #2.
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Figure 5.12: Dose vs EPID signal fitting curve.
Figure 5.13: Cross-line profiles of square fields of different field sizes normalized to the 10 × 10
cm2 field as measured by EPID and micro-diamond detector.
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Figure 5.14: Cross-line profiles of step-and-shoot irradiation as measured by EPID and
MapCHECK 2 detector.
5.3 Discussion and conclusion
Relying on the dosimetric characterization of the EPID, the primary goal of EPID image
frame calibration to 2D dose distribution in water is achieved. Image offset correction is
conducted using a conventional method whereas the applied method for dead pixel cor-
rection allows to recover many of the pixels marked as dead when using conventional
thresholding. The created pixel sensitivity map allows to correct for pixel sensitivity with
no dependency on the beam fluence uniformity resulting in a uniform response all over
the EPID without compromising the beam characteristics. Thus, the off-axis compari-
son between EPID measurement and in-water measurement is applicable. The difference
between the two off-axis (OARs) ratios after pixel sensitivity correction is solely repre-
senting differences between EPID and water media. The generated 2D ROAR relies on
the radial interpolation of the mean of the combined in-line and cross-line profiles as-
suming radial symmetry of the 2D dose distribution. However, the radial symmetry is
affected by beam characteristics, which is not perfect due to several factors including tar-
get shape, beam focal spot position and collimator (MLC and diaphragm) alignment and
shape [146]. Though, the asymmetry is still within the acceptable limits recommended
by international committees [147] (i.e. 1%) but adds small uncertainties. The different
response as a function of the energy fluence spectra is accounted for in field size correc-
tion. The parameters of the kernel are derived based on square fields, and consequently,
interpolated for analogous field area making them independent of the field shape. For
complex and continuous modulation of the field shapes, the convolution kernel changes
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Figure 5.15: Comparison of different fields acquired by EPID and MapCHECK 2 detector.
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accordingly. Therefore, image frames are calibrated individually rather than integrally.
Differently, the penumbra correction is based on static kernel which is independent of
beam modulation and thus, frame by frame correction is not vital to the calibration model.
General comments
Choosing a dosimeter for reference or validation measurement is challenging. There is no
single dosimeter that matches the sensitive area, resolution and potential accuracy of the
EPID. Ion chambers are reasonably accurate for large fields but limited for fields smaller
than 4×4 cm2 [148]. Furthermore, ion chambers cannot provide high resolution measure-
ments when used to produce dose profiles due to their relatively large size. Moreover,
1D dosimetry using motorized dosimeter movement requires static field irradiation dur-
ing scanning. MapCHECK 2 is a 2D array detector based on diodes with a sensitive area
equal to 32 × 26 cm2 and pixel spacing of 7 mm. When comparing with EPID resolution
(0.4 mm2), MapCHECK 2 detector is inferior and cannot be used as a reference espe-
cially for penumbra correction. Film dosimetry is the most suitable option to match EPID
resolution, but yet, repeatability and accuracy is found to be not sufficient for referencing.
Thus, choice of the dosimeter depends on the aim in each step of calibration and valida-
tion. Namely, Farmer ion chamber is used for ROAR and large field measurement due
to its reliability and availability. Micro-diamond detector is found to be the best option
for small fields and penumbra correction. For comparing complex fields, MapCHECK 2
detector is used to provide a 2D dose distribution adequate for validation.
On a different note, image lag of the EPID system influences the dose per frame, but not
the integrated dose. The acquisition of several frames before and after the irradiation re-
leases the burden of modeling the beam-ramp up and the signal fall-off as suggested by
other paper [149]. Additionally, the calibration considers low dose irradiation to account
for single frame dosimetry.
Finally, the proposed method provides the 2D dose distribution with accuracy comparable
to reference dosimeters in a water medium but better spatial resolution and set-up time
efficiency. The method is validated for complex and small fields building the basis for
validation of clinical dose delivery such as IMRT/VMAT.
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Chapter 6
3D dose reconstruction algorithm
6.1 Introduction
EPID-based 2D dosimetry has been described and validated in the previous chapters en-
abling the comparison with in-water dosimetry. Similar results with different methodolo-
gies have also been outlined in the literature by several groups (section 3.1.4.1). In prin-
ciple, 2D EPID-based dosimetry satisfies the strict requirements of the IMRT QA proce-
dures. Features like high spatial resolution, large sensitive area, real-time measurements
and high accuracy make EPID favorite in clinics over conventional dosimeters (e.g. 2D IC
array and 2D diode array). Nonetheless, the validation of these methods do not account
for gantry rotation. The first generation of dosimeters for 2D verification was designed to
be irradiated with IMRT delivery sequence under static gantry condition. Considering the
introduction of VMAT, a validation under dynamic gantry condition becomes crucial to
determine that the correct dose is delivered at the correct gantry angle. Thus, doses need
to be assessed during treatment delivery as a function of time or gantry angle. To this
purpose, researchers working on EPID-based dosimetry proposed assessment methods
relying on predicting 2D dose distributions per gantry angle and comparing the predicted
and measured (calibrated) dose distributions based on control points [79] [150]. Other
groups proposed an EPID-based 3D volumetric dosimetry. The EPID image is converted
to fluence, back-projected upstream and then imported to a TPS or to a forward dose cal-
culation engine to calculate the dose delivered either to a phantom or directly the patient
CT [67] [117] [151]. However, 2D or 3D EPID-based dosimetry approaches rely on dose
calculation or image prediction. Hence, accurate dosimetry needs careful modeling of
the dynamics of the MLC, the intensity rate modification, gantry rotation and collimator
rotation employed by VMAT making the forward dose calculation or image prediction a
challenge.
For non-EPID-based dosimetry, commercial devices embedding a 2D detector configu-
ration for 3D volumetric dosimetry have been adopted, such as Octavius R© 4D (PTW,
Freiburg, Germany), Delta4 R© (Scandidos AB, Uppsala, Sweden) and ArcCHECK R©
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(Sun Nuclear Corp., Melbourne, FL). These devices rely on interpolation and extrapola-
tion algorithms to provide a 3D dose distribution to be directly compared to the treatment
plan. They are currently widely used in clinics owing to their ability to provide clinical
significance to patient-specific pre-treatment dosimetric verification thanks to the DVH
analysis, although based on dose interpolation and extrapolation and therefore limited in
spatial resolution. Additionally, the usage of these devices has a restriction in setup posi-
tioning and timing. Therefore, a fast, simple and accurate 3D volumetric dosimetry, inde-
pendent of forward dose calculation, is desirable. This chapter presents an EPID-based,
prediction-free approach developed to reconstruct a 3D dose distribution as imparted to
a virtual cylindrical water phantom to be used for plan-specific pre-treatment dosimetric
verification for IMRT and VMAT treatment plans.
6.2 Material and methods
The 3D dose reconstruction required the definition of two virtual water phantoms. A vir-
tual cylindrical water phantom with a diameter and height of 26 cm was placed at the
iso-center plane. This phantom was represented by a 256 × 256 × 256 matrix in x, y
and z directions with isotropic pixel spacing of 1 mm. Another virtual cylindrical water
phantom with a diameter and height of 32 cm was created as CT DICOM file and inserted
as input to the treatment planning system (TPS) (Monaco R© v5.11, ELEKTA Oncology
Systems, Crawley, UK) to calculate the 3D dose distribution. For EPID reconstruction,
the TPS dose calculation engine used for calibration utilizes the Voxel Monte Carlo algo-
rithm (XVMC) [152] with 1 mm grid size and nominal uncertainty equal to 0.5%. The
different dimension between the reconstruction and the calculation was meant to exclude
the dosimetric complexity accompanying the build-up region. The main idea of the 3D
dose reconstruction is to back-project the planar 2D dose distribution in x and y directions
of the EPID image frame upstream at different depths in z direction, thus obtaining the
reconstructed 3D dose distribution. For each z, a series of mathematical operations are
applied to the back-projected 2D dose distribution to eventually obtain the reconstructed
3D dose distribution by means of summation. These operations are explained in the fol-
lowing.
6.2.1 Geometrical magnification
In back-projection, the planar 2D dose distributions were geometrically demagnified.
Since the photon source may be assumed as a point source and the photon beam as diver-
gent [15], the area A2 at each depth D2 can be interpolated by knowing the area A1 at an
arbitrary depth D1 as shown in figure 6.1(a) according to the following equation:
A2 =
(A1 ×D22)
D21
(6.1)
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where A1 and D1 are the area and the distance from the beam source to the EPID. To
account for geometrical magnification, the back-projected 2D dose distributions were re-
sized to A2 by interpolation of the EPID image frame as defined by D2/D1.
For size validation, a 10×10 cm2 field was reconstructed, and the 50% positions of the
penumbra fall-off of the cross-line and in-line profiles for each level were compared to
the reference profiles for the correspondent level.
Figure 6.1: (a) Divergent photon beam originated from a point source. (b) Illustration of the
image magnification for different levels.
6.2.2 Percentage depth dose (PDD) curve
Series of PDD curves of square fields of 3,5,8,10,15 and 26 cm sides were calculated
using the TPS to describe the primary energy deposition, serving as a calibration for the
reconstructed 3D dose distributions. For all these curves, second degree exponential fit-
ting was applied, and the fitting parameters were extracted to obtain the PDD curve (after
the build-up region) for any field size or field area. The obtained PDD was then mul-
tiplied by the corresponding back-projected distribution, as resulting from the previous
operation.
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6.2.3 Depth specific off-axis ratio
Due to the cylindrical shape of the virtual phantom, the off-axis energy deposition relative
to the central axis is described by a depth specific off-axis ratio. A dose distribution with
square field side of 26 cm (corresponding to 41 cm at EPID level) was calculated using
the TPS. The same field was used to irradiate the EPID and both the simulated and the
reconstructed 3D dose distributions at each depth were normalized to the central dose.
The division between both matrices produced the depth specific off-axis ratio, which was
multiplied to the result of the previous operations.
6.2.4 Depth specific lateral scatter kernel
Square fields of 3, 5, 8, 10, 15 and 26 cm sides were generated using the TPS to describe
the lateral scatter kernel for each depth z and each field size to define the reference 2D
dose distributions. The in-line and the cross-line profiles were then compared to the cor-
responding profiles in the back projected 2D dose distributions. The difference between
the two distributions represented the lateral energy deposition. This scattering effect was
handled in a similar fashion as partial volume effect in imaging [153] [154]. An iterative
optimization algorithm was developed to find size and shape of convolution kernels de-
scribing this lateral energy deposition. The two 2D dose distributions were segmented into
a hot region (pixels with values above 15% of the reference maximum dose) and a cold
region (pixels with values lower than 15% of the reference maximum dose). The iterative
optimization algorithm led to two convolution kernels expressed by a radially symmetric
Lorentz fitting function with 4 coefficients. The coefficients for each depth and field size
used for comparison were saved in a look-up table. The iterative optimization procedure
is schematically illustrated in figure 6.2 and the code implementation is described in ap-
pendix (A). For image frame reconstruction, the field size determined in section 5.1.5 was
used to call the coefficients for each depth and nearest field size. The same segmentation
in hot and cold region was applied to the 2D dose distribution. The correction was there-
fore implemented as a separated convolution and a subsequent merging of the two regions
to reproduce the reference 2D dose distribution.
6.2.5 Rotation
Time labeling of EPID image frames and gantry angle The reconstructed 3D dose dis-
tributions required to be rotated along the in-line direction in accordance with the gantry
angle during irradiation. For IMRT technique, the gantry angle had discrete values for
each beam. On the other hand, the continuous irradiation of the VMAT was matched with
a continuous variation of the gantry angle and the rotation speed as well. Therefore, an
accurate time labeling of the image frames was required. However, Elekta’s EPID does
not embed this information in the file header. Thus, the gantry angles were extracted from
the log file of the linac trajectory, that saves the gantry angle and the time label in the
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Figure 6.2: Schematic illustration of the iterative optimization procedure for a selected depth and
field size. Firstly, the two 2D distributions are segmented to hot and cold regions. Secondly, an
iterative optimization is applied to find the best convolution kernel needed to generate the reference
2D dose distribution out of the back-projected 2D dose distribution. The resulted kernels are saved
in a look-up table.
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Unix timestamp format with a time resolution up to 0.25 s. As the EPID also saves the
Unix timestamp format, EPID image frames were synchronized and labeled with nearest
neighbor (preceding) gantry angle.
Correction for gravitational displacement of the EPID During the gantry rotation, grav-
itational force is applied to the EPID causing a mechanical displacement in the cross-line
(x) direction. To assess the magnitude of that displacement, 10 × 10 cm2 square fields
were acquired for the 360 rotational degrees in intervals of 10 degrees each [155]. By
considering the central cross-line profile at gantry angle 0 degree as a reference, the po-
sition difference of the 50% penumbra fall-off between the reference and the comparing
profiles were recorded. The gantry shift was reported as a function of the gantry angle.
The shifts were fitted as a function of gantry angle using the following formula:
displacement = a1 exp
(−((theta−a2)/a3)2) (6.2)
where θ is the gantry angle and (a1, a2, a3) represents the amplitude, the position and
the width of the fitting function, respectively. After converting the distance to pixel, the
nearest integer to the obtained displacement was used to shift the EPID image frame prior
to 3D dose reconstruction.
The overall steps involved in calibration and reconstruction process are outlined in figure
6.3.
 
Figure 6.3: A flowchart of calibration and reconstruction process. The procedure first converts
the acquired raw image frames into a 2D dose distribution. Secondly, the 2D dose distribution
is back-projected upstream at several depths, hence, depth specific (Ds). The back-projected 2D
dose distribution undergoes several mathematical operations to produce a 3D dose distribution in
a cylindrical water phantom. The whole process is repeated for each image frame.
88
6.2. MATERIAL AND METHODS
6.2.6 Validation and data analysis
The 3D dose reconstruction was validated with respect to measurements based on Oc-
tavius (see 6.4a). Square fields from 3 × 3 cm2 up to 26 × 26 cm2 and several step-and-
shoot irradiations were considered. For initial validation of clinical treatment plans, one
IMRT and one VMAT were considered and the 3D dose reconstructions of the treatment
plans were validated against the 3D dose distribution measured and calculated by Oc-
tavius. Due to the low spatial resolution of the dose distribution from Octavius (2.5 mm)
with respect to the 3D dose reconstruction (1 mm), the 3D dose calculation performed
by the TPS at the desired spatial resolution was also considered. Besides, the TPS calcu-
lation is not affected by the daily setup uncertainties as the measurements. Hence, data
analysis considered the TPS as the reference. Furthermore, five IMRT (two head & neck,
two prostate and one scalp cases) and five VMAT (head & neck, cervix, brain, pelvis and
abdomen plans) were validated as imparted to a virtual water phantom and the 3D dose
reconstructions were compared to the 3D dose calculation performed by the TPS in water
phantom using the same calculation engine used for calibration but with grid size equal
to 2.5 mm to mimic the QA routine conducted in the clinic.
(a) (b)
Figure 6.4: Picture of (a) Octavius setup (b) In-air image acquisition of EPID during a plan
delivery.
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Table 6.1: Optimization algorithm for the 4 coefficients of the Lorentz fitting function y(x) = a/((x
- b)2 + c) +d, where x represents the radial coordinate of the kernel in pixels.
Field size (cm2)
(No. of irradiated pixels)
Depth
(cm) Region a b c d
Kernel size
(pixels)
Sum of squared
difference (Gy)
Hot 2.76 5.00 4.99 5.00 (3,3) 0.182 2
[5865]
5
Cold 0.07 0.00 -2.86 2.98 (5,5) 0.08
Hot 0.07 5.00 3.75 4.50 (5,5) 0.195 5
[38772]
13
Cold -0.04 2.63 -5.00 -5.45 (5,5) 0.30
Hot 0.01 2.31 4.14 4.33 (11,11) 0.8215 15
[359099]
25
Cold 0.21 0.00 2.50 -2.22 (3,3) 0.28
6.3 Results
6.3.1 Validation of PDD curves
Figure 6.5 shows the comparison between the PDD curves obtained from the recon-
structed 3D dose distributions and the reference 3D dose distributions from TPS calcu-
lation for different square fields irradiated with 100 MU. The curves highlight the 6 cm
difference in diameter between the virtual phantom used for 3D dose reconstruction and
the one used for the TPS calculation. The 2D gamma evaluation between the correspond-
ing 3D dose distributions using (3%, 3 mm) criteria resulted in 100% passing rate. In
here, the gamma evaluator was allowed to search circularly (not spherically) in cross-line
(x) and in-line (y) directions for each depth (z). The gamma index profiles along the z
coordinate are plotted in the lower panels of figure 6.5.
6.3.2 Validation of depth specific lateral scatter kernel
The central cross-line dose profiles comparing the reconstructed 3D dose distributions and
the reference 3D dose distribution from TPS calculation for square field sides of 2, 5, 10,
15 and 26 cm are shown in figure 6.6. The gamma evaluation between the corresponding
3D dose distributions using (3%, 3 mm) criteria resulted in 100% passing rate. Similar to
the 2D gamma evaluation conducted in section 6.3.1, the cross-line gamma index profiles
are plotted in the lower panels of figure 6.6. The penumbra of the profiles demonstrates
the accuracy of the optimization algorithm. Table 6.1 shows the results of the optimization
algorithm for the 4 coefficients of the Lorentz fitting function for selected field sizes and
depths, distinguished in hot and cold regions. Figure 6.7 shows an example of a recon-
structed 3D dose distribution of 5×5 cm2 field, compared to 3D distribution calculated
using TPS.
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Figure 6.5: PDD curves of different square fields as obtained from the reconstructed 3D dose
distributions and the reference 3D dose distribution from TPS calculation annotated with scatter
plot of the gamma index resulted from evaluation between each corresponding profiles.
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Figure 6.6: Central cross-line profiles at the iso-center of square fields of different field sizes as
obtained from the reconstructed 3D dose distributions and the reference 3D dose distribution from
TPS calculation annotated with scatter plot of the gamma index resulted from evaluation between
each corresponding profiles
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Figure 6.7: Different views of 3D dose distributions of 5×5 cm2 field calculated using TPS
and reconstructed from EPID image frames followed by gamma comparison between the two
distributions.
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6.3.3 Time labeling of EPID image frames and gantry angles com-
bined with correction for gravitational displacement of the
EPID
The time labeling of EPID image frames and gantry angles enables the integration of
reconstructed 3D dose distributions as a function of time and gantry angle. Figure 6.8
shows an example of recorded messages plotted against acquisition time obtained from
the EPID header file and linac log file.
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Figure 6.8: (a) Linac log file and EPID header file messaging time labels recorded during a VMAT
delivery. (b) Zoomed of the time labels of (a).
For gravitational displacement correction, figure 6.9 shows the recorded EPID gravita-
tional displacements along the cross-line direction per angle in 10 degree steps. The
fitting parameters are: a1= 10.3, a2= 181.4 and a3= 102.6 resulting in residual R2 value
equal to 0.99.
To test the labeling correctness, two separated rectangular shaped fields is created and
planned for continuous irradiation during the 360◦ rotation of the linac gantry resulting in
torus shape 3D dose distribution. The reconstructed image frames were rotated utilizing
the gantry information extracted from the linac log file. Figure 6.10 shows that the inte-
grated distributions compared with Octavius measurement using gamma evaluation with
(3%, 3 mm) criteria resulted in ≈ 96% passing rate.
Figure 6.11 shows an example of reconstructed 3D dose distributions integrated over time,
acquired during a cervix treatment plan for QA delivery purposes.
6.3.4 Validation and verification of clinical treatment plans
6.3.4.1 Validation
Figures 6.12 and 6.13 show different views of the reconstructed 3D dose distributions in
comparison to those produced by Octavius and the TPS for prostate IMRT and head and
94
6.3. RESULTS
0 50 100 150 200 250 300 360
Gantry angle (degree)
0
1
2
3
4
5
6
7
8
9
10
11
12
T
h
e
 r
e
la
ti
v
e
 d
is
p
la
c
e
m
e
n
t 
(p
ix
e
ls
)
EPID displacement
Fitting curve
Figure 6.9: Detected and fitted cross-line shifts of the EPID as a function of the gantry angle.
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Figure 6.10: A torus shaped field measured by Octavius and reconstructed from EPID image
frames followed by gamma comparison between the two 3D dose distributions.
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Figure 6.11: Axial views of reconstructed 3D dose distributions integrated over time during QA
procedure of VMAT cervix treatment plan. The distribution sequence was resolved in 0.57 fps for
illustrating purposes.
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Table 6.2: Passing rates of the global gamma evaluation with (3%, 3mm) criteria for different
IMRT and VMAT plans between the reconstructed 3D dose distribution and the TPS calculation
IMRT Plan passing rate VMAT Plan passing rate
Head & neck
(case #1) 99% Head & neck 95%
Head & neck
(case #2) 99% Cervix 95%
Prostate (case #1) 99% Brain 99%
Prostate (case #2) 98% Pelvis 96%
Scalp 97% Abdomen 96%
neck VMAT plan, respectively. The global gamma evaluation with (3%, 3 mm) crite-
ria, applied between the reconstructed 3D dose distribution and both Octavius measure-
ment and TPS calculation, is shown in the figures for both treatment plans. The recorded
passing rates were 99% and 95% for the IMRT, and 96% and 93% for the VMAT plan,
considering TPS calculation and Octavius measurement, respectively.
6.3.4.2 Verification of different IMRT and VMAT plans
Table 6.2 shows the result of the global gamma evaluation with (3%, 3 mm) criteria be-
tween the reconstructed 3D dose distributions and the TPS calculations for five IMRT
plans and five VMAT plans. The median passing rates recorded for the 10 plans was 97%
and the lowest rate recorded was 95% for head & neck and cervix VMAT treatment plans.
6.4 Discussion and conclusion
The goal of this chapter is to reconstruct a 3D dose distribution as back-projected from the
2D dose distribution in water obtained from EPID image. The method was developed as
an inverse problem solving, making use of step by step optimization algorithms relying on
the physics behind each step. As inverse problem, each optimization algorithm searches
pararmeters that enable a certain model to match the observation (i.e. the reference mea-
surement). Hence, solving the inverse problem requires a reliable reference. In clinics,
obtaining a 3D distribution of dose in a cylindrical water phantom with high accuracy and
good resolution is challenging. A trade-off between accuracy, spatial resolution and 3D
distributions has to be considered to reach the optimum solution for QA proposes. The
Octavius was the best available option to provide a reference measurement. In addition
to its relatively poor resolution, Octavius measurements failed to give 100% passing rate
when comparing with TPS calculations for IMRT and VMAT plans using gamma evalu-
ation. Thus, referencing Octavius leads to additional deviations from TPS calculations.
Accordingly, the 3D dose distribution generated by the TPS was considered to be the
reference for the proposed calibration. However, details on the specific discussions and
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(b)
Figure 6.12: (a) Coronal, sagittal and axial views of 3D dose distributions of prostate (case #1)
IMRT calculated by the TPS, measured by Octavius (Oct) and reconstructed (Rec) from EPID. (b)
Different views of 3D gamma evaluation between the 3D dose distributions of the TPS calculation
and reconstructed from EPID and between the 3D dose distributions of the Octavius measurement
and reconstructed from EPID.
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Figure 6.13: (a) Coronal, sagittal and axial views of 3D dose distributions of head and neck
VMAT calculated by the TPS, measured by Octavius (Oct) and reconstructed (Rec) from EPID. (b)
Different views of 3D gamma evaluation between the 3D dose distributions of the TPS calculation
and reconstructed from EPID and between the 3D dose distributions of the Octavius measurement
and reconstructed from EPID.
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assumption that were made for each step are outlined below.
6.4.1 Geometric magnification
Geometric magnification determines the resizing factor for each depth resulting in 2D im-
age pixel sizes of odd or even numbers. When back-projecting, the resized smaller image
was aligned to the center of the previous image. The difference between the two image
sizes at the edges was filled with zeros. As the difference could be odd or even, a shift of
one pixel in either x or y directions was required. The correct shift direction was decided
upon the reference penumbra position. When comparing, the 50% positions for some
levels located between two pixels. The shift direction considered the nearest position was
yielding a sub-millimeter shift from the correct position. The shifting effect appeared in
low depth levels (away from EPID) where interpolation is highest and data were missing
due to the decrease in resolution as shown in figure 6.7. Optimizing the geometric mag-
nification is feasible by increasing the spatial resolution of the reference 3D images and
interpolate the value at the desired pixel position. An attempt towards the improvement
of geometric magnification was implemented. Particularly, the spatial resolution of the
3D image was increased to accommodate the smallest resizing. However, the additional
computational resources required by that, including computation time, could not justify
the negligible improvement of the outcome.
6.4.2 PDD curves and lateral dose profile
The comparison between the reconstructed 3D distributions and reference distributions
resulted in ≈ 100% passing rate using gamma evaluation. However, a less than 0.5%
deviation was noticed at the phantom edges due to the deviation in fitting functions used
for reconstruction. Nonetheless, Despite testing different fitting functions in an effort to
improve the results, similar residual R2 values were obtained.
For the lateral dose deposition, the optimization algorithm generates kernels that produce
dose distributions comparable to the reference. When comparing lateral profiles, gamma
index showed ≈ 100% passing rate (figure 6.6). Though, the effect of hot- and cold-
image recombination appears at the 15% dose level for each field. Smoothing the fall-off
pattern can be performed but requires additional interpolation with no significant impact
on the comparison.
6.4.3 Time labeling efficiency and the correction for gravitational
displacement
Figure 6.8 shows recorded messaging time generated by the linac control system and
EPID acquisition system with millisecond resolution. The not perfect linearity noticed in
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messaging times of linac trajectory in addition to the offset in clock synchronization have
negligible impact on time labeling especially when rounding the temporal resolution to
hundreds of millisecond required for our proposes.
With default gantry rotational speed in VMAT delivery of about 1 degree per second and
around 2.5 messages per second, the uncertainty of frame labelling is around±0.4 degree
in comparison to ±1.5 degree for Octavius [156]. The difference between the labeling
accuracy was noticed in torus field test (figure 6.10). In addition to the effect on matrix
rotation, labeling image frames with gantry angles enable correcting for the gravitational
displacement of the EPID which was found to be up to 4 mm. The correction has a
positive impact on gamma evaluation when using static gantry irradiation (IMRT) and
continuous irradiation (VMAT).
6.4.4 Validation
For validation of clinical plans, gamma evaluation with (3%, 3 mm) criteria was used due
to its ability to detect various dosimetric deviations [61]. The comparison was conducted
against detector measurement and dose calculation. As the accuracy of the reference mea-
surement affects the evaluation of the obtained results, the 3D dose reconstruction con-
sidered the 3D dose distribution from TPS calculation as a reference due to its achievable
spatial resolution. However, since the calibration relied on TPS calculations, the discrep-
ancies noted in the gamma evaluation (figure 6.12(b) and 6.13(b)) between Octavius and
the 3D dose reconstruction were expected [157]. The evaluation for the different IMRT
and VMAT plans in table 6.2 showed a passing rate exceeding the common tolerance level
(i.e. 95%) [158] for the selected treatment plans.
Finally, as mentioned earlier, the 3D dose reconstruction relied on inverse problem
solving. Each step contributes to the overall accuracy as well as to the overall acquisition
time of the proposed methodology. For instance, EPID is characterized by a dose rate de-
pendency which affects the accuracy of the reconstructed 3D dose distribution of VMAT
treatment plans. In this study, no dose rate dependency corrections are performed. The
maximum deviation of the cumulative dose detected by EPID with respect to ion cham-
ber measurements is estimated to be ≈ 1.5%. A correction for dose rate dependency is
expected to improve results in terms of gamma evaluation, reaching passing rates com-
parable to IMRT treatment plans. However, it extends the calibration time and requires
additional information from the linac log file.
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Chapter 7
Sensitivity analysis of EPID-based 3D
dose reconstruction
7.1 Introduction
The proposed method has been validated for dosimetric accuracy for complex clinical
plans. However, the rationale of this thesis is to establish a sensitive tool for plan-specific
dose delivery QA. In general, the sensitivity of such tool quality is evaluated by its mer-
its to catch errors before the dose delivery. Through the radiation therapy chain, dose
delivery is vulnerable to several types of errors especially with the introduction of com-
plex treatment techniques. IMRT and VMAT, for example, exploit various mechanical
and dosimetric degrees of freedom making the precise interplay and coordination of each
parameter essential for correct dose delivery. Hence, current technology offers numerous
error sources. The goal of this chapter is to investigate the sensitivity of an EPID-based
3D dose reconstruction algorithm to detect geometric and dosimetric errors in VMAT
plans.
7.2 Material and methods
A typical VMAT plan for head & neck case was generated using the TPS (Monaco R©
v5.11, ELEKTA Oncology Systems, Crawley, UK). The plan was delivered using the
linac and the image frames were acquired during delivery using the calibrated EPID. The
acquired frame images were reconstructed to a 3D dose distribution with 1 mm isotropic
resolution using the developed algorithm from chapter 6. The resulted distribution was
evaluated against the TPS dose distribution in a cylindrical water phantom. In parallel,
intentional dosimetric and geometric errors were introduced in the original treatment plan.
For geometric sensitivity testing, firstly, two selected neighboring leaves were shifted
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by 2 mm in all control points of the original treatment plan file. Secondly, a 1 degree
controlled rotational shift of the gantry angles was applied. For dosimetric sensitivity
testing, the total monitor units of the original plans were increased by 4%.
The resulting 3D dose distributions were compared to the original plan using global
gamma evaluation with (3%, 3 mm) as acceptance criteria.
7.3 Results
Figure 7.1 shows different views at the iso-center of the original head & neck case de-
livered to a virtual cylindrical phantom as calculated by the TPS and reconstructed from
the EPID image frames. The gamma evaluation between the two distributions resulted in
98.81% passing rate.
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Figure 7.1: Coronal, sagittal and axial views of the original 3D dose distributions calculated by
the TPS and reconstructed for head & neck VMAT delivery and the gamma evaluation between
the two distribution.
The reconstructed 3D distribution of the modified plan with 2 leaves shifted with 2 mm
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and its gamma evaluation against the original plan is showed in figure 7.2. The evaluation
resulted in passing rate 91.72%.
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Figure 7.2: Different views of the reconstructed 3D distribution at the corresponding slice of the
modified plan with 2 leaves shifted with 2 mm and the gamma evaluation against the original plan.
The reconstructed 3D distribution of the modified plan with 1◦ rotational shift and its
gamma evaluation against the original plan is showed in figure 7.3. The evaluation re-
sulted in passing rate 96.33%.
The reconstructed 3D distribution of the modified plan with additional 4% dose is shown
in figure 7.4 along with the gamma evaluation against the original dose distribution cal-
culated by the TPS. The gamma evaluation resulted in 76.55%.
7.4 Discussion and conclusion
The head & neck VMAT case was considered for the sensitivity test due to the associated
complexity including a wide range of fields sizes, dose rates and the full rotation of the
gantry. In principle, the sensitivity of the algorithm should be higher for less complicated
plans in terms of field sizes, dose rates and gantry angles (e.g. brain VMAT, head & neck
IMRT etc). The design of the test conducted in this chapter regarded those parameters
required to be verified in a patient specific QA [61]. Namely, verification of MUs, data
transfer, and dose delivery. Moreover, the sensitivity test was designed to check the feasi-
bility of the proposed reconstruction methodology to detect mechanical malfunctioning.
The gamma evaluation was used for analysis due to its simultaneous criteria of geometric
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Figure 7.3: Different views of the reconstructed 3D distribution at the iso-center of the modified
plan with 1◦ rotational shift and the gamma evaluation against the original plan.
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Figure 7.4: Different views of the reconstructed 3D distribution at the iso-center of the modified
plan with 4% over dose and the gamma evaluation against the original plan.
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and dosimetric differences. The values chosen for the evaluation criteria (i.e. 3% and
3mm) were assessed after having explored several values, the chosen evaluation criteria
produced the desired sensitivity matching the accuracy achieved by the methodology. The
algorithm demonstrated to be capable of catching geometric errors of MLC in order of 2
mm, gantry angle shift of 1 degree and dosimetric error of ±4%.
In particular, when shifting the two leaves 2 mm away from the original position, the pass-
ing rate was reduced by 7.09%. Using a 3D visualization of the gamma index distribution,
position and deviation were detected. For rotational shift, the passing rate reduction was
relatively small (i.e. 2.48%) leaving overall passing rate above the threshold (i.e. 95%).
Though, the rotational shift effect was visible in the 3D visualization.
For the dosimetric sensitivity test, the additional 4% dose caused a reduction of the pass-
ing rate equal to 22.26%. The overdose was indicated in the high dose region while minor
effect was observable for the low dose region.
For both geometric and dosimetric parameters, stricter gamma criteria can in principle
increase the sensitivity to errors. However, since the development of the reconstruction
algorithm was designed to pass the gamma evaluation with (3% and 3mm) criteria, the
distinction between the deviation related to accuracy or to error in delivery (less than
introduced in this chapter) becomes more challenging.
On the other hand, the required sensitivity depends on the clinical relevance of the devi-
ation. In particular, the sensitivity of the proposed methodology meets the requirement
used by our clinic.
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Discussion and outlook
The primary objective of this work was to develop a patient-specific QA tool based on
EPID. The dosimetric characterization of the used EPID showed technical challenges
when using it as a dosimeter in clinical practice. Some of the challenges were related
to the physical properties of a-Si detectors such as their non-water equivalent energy
response. Other challenges were related to a specific model of EPID or image acqui-
sition software from a particular vendor. The difference between models was presented
by comparing dosimetric properties of different EPIDs reported in the literature. Accord-
ingly, a novel method for converting 2D images to dose in water specific for the adopted
model was developed. The calibration method was validated for complex radiation fields
against different dosimeters. Consequently, a 3D dose reconstruction method was devel-
oped based on a series of mathematical operations. The method was solely dependent
on the TPS during calibration. As a result, a prediction free 3D dose distribution was
obtainable with good accuracy and high spatial resolution even for complex fields. The
reconstructed 3D dose distributions of clinical IMRT and VMAT plans were validated
against measurements and dose calculation resulting in passing rates that exceeded the
recommended limits. The overall method of calibration and reconstruction proved to be
sensitive to clinically relevant geometric and dosimetric errors, thus making the approach
a good choice for plan-specific QA thanks to superior spatial resolution and comparable
accuracy with respect to a commercial dosimeter. Additionally, in air acquisition of im-
ages paves the way towards fully automation of a pre-treatment QA procedure. During the
method development process, image acquisition and dose reconstruction were performed
on two separate computers. However, in order to achieve the minimum human interven-
tion, a simple interface was developed for image acquisition and dose reconstruction in
single PC dedicated to EPID dosimetry. For daily clinical pre-treatment QA routine, the
QA procedure required only EPID unfolding and alignment to the center of the field.
Then the in-air acquisition of the image frames is performed by one click. Currently, the
3D dose reconstruction takes roughly 8 seconds for each image frame. For instance, the
irradiation of the head & neck VMAT treatment plan took about 3.7 min and resulted
in 510 image frames. By using a personal computer equipped with a 3.40 GHz CPU
(Intel R© Core TM i7-6700) and 32.0 (GB) RAM, the 3D dose reconstruction required
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about 45 min. Parallel computing on a multi-cores computer can considerably reduce
the computation time of repetition cycle (i.e. ”for loop”). On the other hand, the cali-
bration processes currently requires human intervention in several steps. The calibration
approach relied on mathematical operations (namely: curve fitting, interpolation ...) and
optimization algorithms. As outlined in appendix (A), the optimization is designed to
generate convolution kernels converting an input image to the desired output. The opti-
mization algorithm searches for the single global minimum in the parameter space. The
convergence between global or local minima depends on several factors such as the op-
timization algorithm and the abundance of available information on the parameter space.
For each step, an optimization algorithm was implemented so that the overall calibration
approach results as a serious of operations to be performed.
Machine learning algorithm (ML) is a group of computational methods that make use of
statistical information about input data to achieve a desired task -without being explicitly
programmed- or to produce a particular outcome [159] [160]. Ideally, ML can emulate
human decision making after conducting several learning mechanisms to reach the ulti-
mate goal. ML can be applied to any desired discipline in different forms. Envisioning an
ML application to the proposed calibration process, three components could be identified:
1) statistical modeling of the parameters, 2) evaluation of the outcome based on initial pa-
rameters and 3) optimization of the initial parameters. The logic flow-chart of the process
is similar to the optimization process used in the calibration. However, the current opti-
mizer deals with a single parameter for each calibration step. For ML, all the steps could
be accounted for in a set of parameters, and the learning process is supervised to reach
the ultimate goal. Using the high number of iterative cycle, the optimal combination of
convolution kernels and fitting functions could be obtained without human intervention.
8.1 Plan evaluation
In this thesis, gamma evaluation was the adopted method to assess the quality of the dose
delivery in comparison to the planned one. The acceptance criteria were chosen in accor-
dance to recommendations and general guidance reported in literature [61]. A recently
published report by AAPM considered different QA programs practiced in numerous clin-
ics [161]. Several IMRT patient-specific QA programs and evaluation methods using
different types of dosimeters have been reported. Each of these clinics determines their
tolerance limits in conjunction with other metrics to serve the final goal of the QA pro-
gram taking into consideration the technical boundaries of the used QA tool. The report
recommends that a universal tolerance limit of gamma passing rate of ≥ 95% with (3%,
2 mm) should be considered. However, this tolerance limit in gamma evaluation resulted
too strict for the accuracy of the proposed method, which would require a refinement. On
the other hand, some researchers have criticized the gamma evaluation standalone, stating
that it cannot predict clinically relevant error [162]. In particular, the passing rate metric
could not distinguish between insignificant low dose error and significant overdose to or-
gans at risk. Therefore, DVH has been introduced as an essential tool for patient-specific
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QA. As deriving the DVH requires 3D dose distribution, 2D detectors were developed
to reconstruct a 3D distribution. Commercial devices currently could provide such a dis-
tributions but, yet, they are based on dose interpolation and extrapolation and therefore
limited in spatial resolution. A major concern when using the 3D distributions for gen-
erating DVHs is that they are measured (and interpolated) in a water equivalent phantom
with iso-center and material composition different than those of the patient. This affects
the accuracy of the DVH, considering that DVH has been introduced to evaluate the dose
calculation accuracy. Validation of the dose calculation accuracy has a fundamental role
in patient-specific QA. However, current TPS do not include an accurate modeling of
the MLC and surrounding collimators [18] [163]. Besides, dose calculation based on
analytical algorithms proved to have uncertainty up to 4.9% in inhomogeneous phantom
[164]. Consequently, the usage of an accurate, independent and machine-specific dose
calculation engine is essential for implementing an integrated patient-specific QA. For
this reason, we put forward a new approach in QA procedures composed by two separate
stages: a plan-specific dose delivery and a patient-specific dose calculation.
8.2 Toward a comprehensive patient-specific pre-
treatment QA
As demonstrated in this thesis, reconstruction of 3D dose distributions using EPID pro-
vided a robust tool for plan delivery verification of complex treatment plans. The method
was proved to be sensitive to geometric and dosimetric errors prone to be generated by
mis-transferring of data between planning and controlling systems or malfunctioning of
linac components. The integrity of the dose calculation within the patient anatomy would
need an additional tool for verification. To this purpose, an equipment-specific MC model
(implemented in GEANT4) was developed in the framework of another phd project for the
Elekta Agility collimator (see 8.1)[55]. The model was used for simulations of the dose
distribution of IMRT and VMAT treatment plans in a patient CT. The model includes
detailed features of each component in the linac head and t is embedded in a code that
converts the DICOM file of the patient CT to attenuation coefficients at the exact position
of the patient. Furthermore, the code reads the RTPLAN DICOM file and translates the
information to parameters used for MLC positions, dose rates and gantry angle. Although
the model is still in the validation phase, the dose calculation accuracy is potentially better
than analytical based calculation engines. Once the model is validated for homogenous
and inhomogenous phantom, it could be used for patient-specific pre-treatment verifica-
tion of dose calculation. Furthermore, the calculation of the DVH would gain in accuracy,
being based on the accurate modeling of patient anatomy.
This dose calculation verification together with the plan-specific QA tool developed in
this thesis would make the pre-treatment QA more robust and sensitive to errors that could
occur in the radiation therapy work-flow. A flowchart of the proposed QA procedure (and
its two constitutional stages) is outlined in figure 8.2.
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Figure 8.1: The GEANT4 model of the ELEKTA synergy linac and the CT of a water phantom
(courtesy S. Veloza and J. Martin).
Pre-treatment QA
Patient specific QA Plan specific QA
Dose delivery
EPID based 3D
 dose reconstruction
Dose calculation
MC dose calculation
 based on GEANT4
Figure 8.2: A flowchart of the pre-treatment QA procedure and its two constitutional stages.
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However, the drawback of the MC implementation for dose verification is the computa-
tional time required to achieve statistically adequate accuracy and precision. Currently,
the developed model needs a few hours to simulate a full IMRT treatment plan. The sim-
ulation time is set to be reduced significantly using parallel computing. In order to not
affect clinical routine, the MC calculation could be performed overnight. Though, parallel
computing opens opportunities for more time efficient QA procedures.
8.3 In-vivo dosimetry
EPID-based in-vivo dosimetry has proliferated in the past few years. The final aim is
to provide an accurate and independent dose verification of the treatment delivery. In
addition to sensitivity to errors in dose calculation, data transfer, and dose delivery as
in pre-treatment QA, in-vivo dosimetry would enable the identification of errors gener-
ated by patient setup and changes in patient anatomy. However, current applications of
EPID-based dosimetry are focused on pre-treatment dose verification and applications for
in-vivo dosimetry are still limited. In brief, the proposed concept for EPID-based in-vivo
dosimetry relies on either predicting images at the EPID level through patient anatomy
extracted from the treatment planning CT or estimating fluences from the EPID image to
forward calculate the dose as imparted in the patient CT. The ability of both approaches
to detect errors undetectable by a solely pre-treatment QA has been demonstrated by
different groups [120] [123] [135]. All these methods were very sensitive to anatomi-
cal changes. Although this is one of the main advantages of in-vivo over pre-treatment
dosimetry, the interpretation of observed differences between measured and predicted 3D
dose distributions is complicated. Since the in-vivo methods rely on the treatment plan-
ning patient CT, the generated dose distribution is valid for dose verification only and
is not representative of the ”true” dose delivered to the patient. Consequently, when a
deviation is detected, the decision making for re-planning or other adaptive strategies
is performed qualitatively by visual inspection of the CBCT acquired prior to treatment
[165]. Indeed, implementing the in-vivo dosimetry provides a better safety net for the
treatment delivery in comparison to full dependence on pre-treatment QA. However, it is
still a dosimetric verification tool rather than independent dosimetry, and its accuracy is
associated with good modeling of the linac components and modulation (e.g. MLC move-
ment) and patient anatomy. As an alternative approach to EPID-based in-vivo dosimetry,
the proposed comprehensive patient-specific QA, including the plan-specific QA object
of this thesis work, is planned to be implemented in our clinic.
The rationale for in-vivo dosimetry is to verify patient setup and patient anatomy which
have not been verified by the patient-specific QA. The proposal is based on using a daily
CBCT acquired prior to dose delivery with interpolated MLC positions from EPID images
and doses measured by linac monitor chambers. All these data are imported into the
machine-specific MC calculation engine to generate a 3D dose distribution. Thus, the
proposed in-vivo dosimetry is independent of TPS calculation or patient planning CT. The
generated 3D dose distribution can be compared to the planned distribution using gamma
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evaluation or DVH. Consequently, in case of detected deviation, the decision making
can be guided by quantitative evaluation with higher confidence level. Additionally, the
in-vivo 3D dose distributions of both fraction by fraction and/or dose accumulation can
be stored and used for auditing purposes. The feasibility and proof of concept of this
proposal are yet to be tested. Factors like the additional dose due to imaging to the patient,
the extended computational time and the added workload on staff have to be considered
with respect to the outcome benefit.
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Conclusion
Treating cancer tumor with photon radiation has begun nearly a century ago. As the tech-
nology proliferated in the last two decades, the techniques of delivering radiation dose
have been enormously developed in terms of accuracy and precision. The improvement
has made use of complex auxiliary systems attached to the linac aiming at the best con-
forming of the dose to the tumor in conjunction with the best dose sparing of healthy
tissues. Currently, the delivery of the radiation dose reached an unprecedented level of
accuracy, thanks to the advancement in linac mechanics and its control system along with
its authentic dose calculation engine. However, in order to fully exploit the anticipated
advantages of the accuracy of the current technology, a robust QA program has to be con-
ducted. As the introduction of supporting systems to the treatment chain increases, new
measures for the QA program has to be introduced as well. Yet, this accompaniment is
not optimum since the development of the QA methods and apparatus has been slower
than the treatment technology.
For complex treatment delivery techniques in radiation therapy such as IMRT/VMAT, a
patient-specific QA approach has been recommended. This approach requires, in addition
to independent dose calculation engine, a dosimetry system with high accuracy and res-
olution and preferably able to generate a 3D dose distribution. Dosimeters with such (or
approaching these) characteristics are commercially available but with the limitation of
increased set-up time. The EPID, a built-in imaging detector in most modern linacs poses
potential dosimetric features. In this thesis, the dosimetric features of a specific EPID have
been explicitly investigated. Making use of the knowledge gained from EPID characteri-
zation, a method to calibrate EPID to be used as a dosimeter in water has been presented.
Converting a the 2D image, as acquired from EPID, into a 2D dose distribution enables the
comparison with reference dosimeters. The accuracy of the calibration method has been
validated for regular QA tests and real clinical scenarios. As this calibration presents a
useful tool for QA programs, the advantage of producing 2D dose distributions with high
accuracy and resolution with no need for human intervention in either detector positioning
nor passive processing (as in films and TLDs). In fact, the trend of QA tool development
tends to march toward 3D dosimetry. Accordingly, a novel approach to reconstruct a
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3D dose distribution from 2D dose distributions has also been developed in this thesis.
A series of mathematical operations have been explicitly implemented to generate a 3D
distribution matching the desired spatial resolution and having comparable accuracy with
the TPS dose calculation. The operations resulted in an algorithm that back-project the
2D dose distributions at different levels thus forming (reconstructing) a 3D dose distribu-
tion. Additionally, the back-projection mimics energy deposition and attenuation as in a
virtual cylindrical phantom. Therefore, the reconstructed 3D dose distributions have been
validated for conventional and complex clinical treatment plans against reference mea-
surements. The methodology has also been tested for sensitivity to small geometric and
dosimetric deviations, satisfying the required criteria.
As the aim of this thesis is to develop a QA tool for patient-specific QA, the developed
work presents a preferable methodology over others proposed in literature and also over
commercial devices. The advantages of the presented work are the fast and in-air acquisi-
tion of the measurements combined with a non labor intensive set-up, and the prediction-
free (except in calibration process) and the water-equivalent features of the reconstructed
3D dose distribution with relatively good accuracy and optimal and desired spatial res-
olution. These advantages represent favorable characteristics for clinical dosimetry and
specifically for patient-specific QA program. Besides the clinical application demon-
strated in this thesis, the methodology can be used for research and auditing purposes.
As final remark, the remaining limitation of the proposed methodology is the current
implementation of the calibration process. However, technical improvements of the im-
plemented codes are foreseen. The development includes a user-friendly interface, opti-
mization of computational time and generalization to other EPID models.
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Mathematical optimization and code
implementation
A.1 Overview
Mathematical optimization is the process to search the best solution out of a set of possible
choices with respect to a pre-specified criterion. Depending on the criteria, the optimiza-
tion process consists of minimization or maximization (depending on the criteria) of the
objective function f (x), where x is an N-dimensional vector referred to as the parameters
of variables within is the feasible set S (search space). Typically, the optimization con-
sists of iterations where the vector of parameters minimizing or maximizing the objective
function is carried on. The search space can be limited by constraints, such that h(x) =
c and g(x) ≤ d [166]. The feasible solution that minimizes or maximizes the objective
function is the optimal solution. The optimal solution can be either a global or local min-
ima . While local minimum applies for a neighborhood, the global one applies for the
entire search space S. An example of different minima of the function in equation A.1 is
illustrated in figure (A.1).
h(x) = 2 + cos(x) +
cos(2x− 0.5)
2
(A.1)
Several algorithms have been proposed for solving optimization problems. However,
many solvers suffer from distinguishing between global and local minima. Therefore,
global optimization mathematics and numerical analysis tools were developed as sup-
porting algorithms for problem solvers. As a result, the optimization code constitute of
a problem solver and analysis tools to verify the best solution from a set of input values
from within an allowed set, computing the output of the function and recording the best
output values found during the process.
117
APPENDIX A. OPTIMIZATION ...
Figure A.1: Local and global minima for function A.1.
Figure A.2: The steps of the methodology presented in this thesis that required an optimization
process are marked with red square in the flowchart.
A.2 Code implementation
MATLAB in conjunction with Optimization ToolboxTM offers several algorithms for nu-
merical optimization. The optimization processes implemented in this thesis relied on
MATLAB. The steps of the methodology (EPID calibration and 3D dose reconstruction)
that required an optimization process are marked in figure (A.2). The choice of the algo-
rithm and the implemented objective function are outlined in the following.
• Field size correction the aim of this optimization was to obtain the single param-
eter relevant to the exponential fitting function defining the field size dependent
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convolution kernel. The objective function to be minimized was the square differ-
ence between the reference measurement and the central values of the integrated
image frames. A non-linear, unconstrained and derivative-free algorithm as imple-
mented in ”fminsearch.m” was used. Details of the optimization process are in the
following.
FS correction
• Penumbra correction the objective function was defined as the sum square differ-
ence between the two profiles measured by the reference detector and the image
frame. As the required convolution kernel was modeled by a Lorentz fitting func-
tion with 4 coefficients (vector of parameters), the initialization parameters were
guessed randomly. Details of the optimization process are in the following.
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Penumbra correction
• Depth specific lateral scatter correction two convolution kernels and therefore
two separated optimization processes were considered, corresponding to the seg-
mented hot and cold regions of the image frame. The optimization function was the
sum square difference of the mean between the in-line and cross-line profiles. The
convolution kernel was modeled as a Lorentz fitting function with 4 coefficients. In
this step, the algorithm implemented in ”fminsearch.m” converged to local minima.
To try to approach global convergence [167], the algorithm particle swarm was used
with certain constraints. As the ”particle swarm” algorithm is a population-based
optimization method (inspired by the motion of a bird flock, or fish schooling),
the computation speed is slower than a derivative- free method. The optimization
process implemented to generate the two kernels parameters is below.
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Depth specific lateral scatter 
correction
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Finally, it is worth mentioning that the choice of the optimization algorithms excluded
those not embedded in MATLAB. Better results in terms of accuracy and precision and
better performance (computational speed, depending on the applicability of parallel com-
puting) can achieved with different algorithms.
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qa passing rates do not predict clinically relevant patient dose errors. Medical
physics, 38(2):1037–1044, 2011.
140
BIBLIOGRAPHY
[163] Shifeng Chen, Byong Yong Yi, Xiaocheng Yang, Huijun Xu, Karl L Prado, and
Warren D D’souza. Optimizing the mlc model parameters for imrt in the raystation
treatment planning system. Journal of applied clinical medical physics, 16(5):
322–332, 2015.
[164] Stephen F Kry, Paola Alvarez, Andrea Molineu, Carrie Amador, James Galvin,
and David S Followill. Algorithms used in heterogeneous dose calculations show
systematic differences as measured with the radiological physics center’s anthro-
pomorphic thorax phantom used for rtog credentialing. International Journal of
Radiation Oncology* Biology* Physics, 85(1):e95–e100, 2013.
[165] Lucas CGG Persoon, Ada GTM Egelmeer, Michel C Öllers, Sebastiaan MJJG Ni-
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